{"meta":{"query_hash":"3276d03249a7","filters":{"venue":"Inpharma Weekly"},"cohort_total":85,"direct_labels_cover":0,"predictions_cover":85,"exported":85,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/3276d03249a7","api":"https://metacan.xera.ac/api/v1/cohort?venue=Inpharma+Weekly"},"results":[{"id":"W1986963851","doi":"10.2165/00128413-200213280-00030","title":"Canadian study supports alteplase use outside tertiary care setting","year":2002,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Cardiac, Anesthesia and Surgical Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Tertiary care; Pharmacy; Medical emergency; Family medicine","score_opus":0.01805097595681214,"score_gpt":0.2690910662904095,"score_spread":0.25104009033359737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986963851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7874251,0.0107662575,0.00082335545,0.044999007,0.00090863515,0.00032075823,0.020345,0.0001215308,0.1342904],"genre_scores_gemma":[0.98336464,0.0020884313,0.0005272468,0.006120307,0.00020639673,0.000041872416,0.0013288264,0.00004256265,0.006279638],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99718297,0.00046545238,0.00028169446,0.00034061394,0.0010783294,0.0006509379],"domain_scores_gemma":[0.97580886,0.0058391583,0.004717902,0.00084214367,0.009105476,0.0036863864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019003385,0.00027229683,0.0005475312,0.001262983,0.002735611,0.0021175535,0.0012005343,0.0008405084,0.020152263],"category_scores_gemma":[0.016437335,0.0002997686,0.0008910971,0.002521603,0.0006893471,0.0007204699,0.0005592718,0.0015893808,0.0006549622],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009648998,0.0001481525,0.9453248,0.00034133275,0.00028223416,0.00054535357,0.00045809336,0.00009462121,0.0002892668,0.0014791709,0.03084923,0.019222895],"study_design_scores_gemma":[0.00024960088,0.00010623152,0.9797537,0.00042216503,0.00040184736,0.00040238327,0.0013252025,0.00023643798,0.00026635735,0.0002017647,0.016592901,0.000041403557],"about_ca_topic_score_codex":0.9482026,"about_ca_topic_score_gemma":0.9735076,"teacher_disagreement_score":0.05179739,"about_ca_system_score_codex":0.010710656,"about_ca_system_score_gemma":0.039164852,"threshold_uncertainty_score":0.10420483},"labels":[],"label_agreement":null},{"id":"W2031093133","doi":"10.2165/00128413-200213260-00017","title":"Best case needed to see oseltamivir's value for flu in Canada","year":2002,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Oseltamivir; Medicine; Value (mathematics); Pharmacy; Virology; Coronavirus disease 2019 (COVID-19); Statistics; Family medicine; Internal medicine; Mathematics; Infectious disease (medical specialty)","score_opus":0.04792130752394808,"score_gpt":0.29574083098371967,"score_spread":0.2478195234597716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031093133","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020554777,0.021609778,0.00027261916,0.8748304,0.010543997,0.00022075666,0.0024344972,0.00014003845,0.06939314],"genre_scores_gemma":[0.3333826,0.032152675,0.0041340357,0.51186985,0.008727463,0.00021255904,0.0022754571,0.00014492543,0.10710042],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997593,0.0004188974,0.00016761625,0.0001226253,0.00070925045,0.000988645],"domain_scores_gemma":[0.983324,0.0017112858,0.00036320687,0.00018751007,0.007358991,0.0070550973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024912923,0.00045685013,0.0007248292,0.0011554627,0.005121182,0.003819587,0.0017050073,0.010503787,0.026687723],"category_scores_gemma":[0.010216265,0.00032033186,0.00096277834,0.0008861844,0.0016872181,0.0016764412,0.0012561602,0.0043727956,0.0015997216],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001837245,0.0002922637,0.029797819,0.0008722711,0.00016483649,0.0042987457,0.00048733357,0.001049919,0.0012884362,0.011205621,0.86410135,0.08460415],"study_design_scores_gemma":[0.0013691635,0.00053165015,0.07477458,0.0029446147,0.00045133277,0.0016603209,0.0051974375,0.0013874009,0.0014307061,0.008941207,0.90104234,0.00026927947],"about_ca_topic_score_codex":0.94909304,"about_ca_topic_score_gemma":0.97525316,"teacher_disagreement_score":0.050906956,"about_ca_system_score_codex":0.03268018,"about_ca_system_score_gemma":0.15662633,"threshold_uncertainty_score":0.23711246},"labels":[],"label_agreement":null},{"id":"W2059851348","doi":"10.2165/00128413-200112810-00011","title":"Canada chooses its weapons in the battle against influenza","year":2001,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Battle; Medicine; Virology; Ancient history; History","score_opus":0.10522840513394786,"score_gpt":0.38760391904179486,"score_spread":0.282375513907847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059851348","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.038816176,0.025937293,0.00028302224,0.7413586,0.0052760085,0.00012851764,0.004012071,0.00006120014,0.18412721],"genre_scores_gemma":[0.40268865,0.04084319,0.0017641,0.20813647,0.0022946517,0.00013294877,0.0017192287,0.00016240016,0.3422583],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946557,0.0011899708,0.00012089791,0.00017196502,0.002151545,0.0017099183],"domain_scores_gemma":[0.9881295,0.0016290854,0.0003221923,0.0002767727,0.0042970506,0.005345466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005688474,0.00038095127,0.0005676792,0.0021670908,0.013675192,0.009346251,0.0013485118,0.003930498,0.02026069],"category_scores_gemma":[0.011440607,0.0003752005,0.00034778038,0.004240959,0.004207217,0.0020350155,0.002177277,0.004899204,0.0019514896],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000420781,0.00014474533,0.025723614,0.00020107822,0.00007533267,0.00018646863,0.0024171062,0.00018128745,0.00038804667,0.06710475,0.83582336,0.06733344],"study_design_scores_gemma":[0.00010567848,0.000100955935,0.026713733,0.0003924373,0.000055515575,0.000059837123,0.006807807,0.00010537044,0.00040128824,0.0038468326,0.9613626,0.00004794325],"about_ca_topic_score_codex":0.9891138,"about_ca_topic_score_gemma":0.9965044,"teacher_disagreement_score":0.9122778,"about_ca_system_score_codex":0.087722205,"about_ca_system_score_gemma":0.27349174,"threshold_uncertainty_score":0.6364721},"labels":[],"label_agreement":null},{"id":"W4205152399","doi":"10.2165/00128413-200514830-00035","title":"Is it bye-bye Bextra in the US, EU and Canada?","year":2005,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Infective Endocarditis Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.022279634870454524,"score_gpt":0.3001602326206158,"score_spread":0.2778805977501613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205152399","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016722832,0.03800641,0.00033007804,0.8279357,0.017301727,0.000042686035,0.0011402178,0.00011836918,0.098402],"genre_scores_gemma":[0.23912708,0.06659809,0.0018494668,0.3076625,0.0043815845,0.00007416954,0.0011221371,0.00028668385,0.37889835],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969428,0.00022792685,0.00011532467,0.0001901745,0.00090491533,0.0016189099],"domain_scores_gemma":[0.99029726,0.0005246743,0.000390661,0.00022896058,0.0040075015,0.0045509962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026843958,0.00032094537,0.00062044745,0.0010533931,0.0059190486,0.0070332456,0.0011695197,0.0049737506,0.04072938],"category_scores_gemma":[0.01030085,0.00032301433,0.0005594954,0.0021745472,0.0036395625,0.0028419625,0.0020029491,0.0049512475,0.0040824884],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018720476,0.000091982496,0.022370035,0.00019598805,0.000043739023,0.0007595181,0.0012529977,0.00007960528,0.00031846028,0.015844893,0.8457131,0.11314241],"study_design_scores_gemma":[0.00003575761,0.000030449019,0.025086291,0.00060780137,0.000032445838,0.0005528324,0.0060507767,0.00007936964,0.0001457262,0.0015287726,0.96580195,0.000047835187],"about_ca_topic_score_codex":0.9326939,"about_ca_topic_score_gemma":0.9567511,"teacher_disagreement_score":0.0673061,"about_ca_system_score_codex":0.017869432,"about_ca_system_score_gemma":0.10750233,"threshold_uncertainty_score":0.13625336},"labels":[],"label_agreement":null},{"id":"W4205563331","doi":"10.2165/00128413-200514820-00086","title":"Health Canada has approved Pfizer's dalteparin sodium [Fragmin],","year":2005,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Health and Medical Research Impacts","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacy; Family medicine; Pharmacology","score_opus":0.13165161942589404,"score_gpt":0.4079476999646185,"score_spread":0.27629608053872445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205563331","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10106169,0.12812492,0.011451948,0.22090022,0.016525969,0.0019341112,0.012116756,0.00996872,0.49791566],"genre_scores_gemma":[0.4323255,0.037735574,0.018916726,0.068079576,0.003113343,0.0003195851,0.008365926,0.00062741066,0.4305164],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99933666,0.00009234448,0.000024527842,0.00007325596,0.000343211,0.00012998005],"domain_scores_gemma":[0.9987393,0.0002511103,0.00012012882,0.00004735867,0.00038870584,0.00045344702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008873872,0.0005656001,0.0005732882,0.00078971696,0.0013185103,0.0009847544,0.0011489175,0.0030453077,0.030761158],"category_scores_gemma":[0.002543343,0.00024864153,0.00063082814,0.0004969041,0.0009159091,0.00036913328,0.0004438461,0.0021106778,0.0057879356],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035535821,0.0007662236,0.0029721532,0.00066204526,0.00006782201,0.0013993008,0.00009173361,0.0002385603,0.022109494,0.0054211062,0.51934046,0.4433776],"study_design_scores_gemma":[0.0015358003,0.0019781168,0.006017169,0.00019496797,0.00012596846,0.0022119402,0.00008244449,0.00045194963,0.013244402,0.00063690636,0.97347397,0.00004647504],"about_ca_topic_score_codex":0.087193474,"about_ca_topic_score_gemma":0.22595595,"teacher_disagreement_score":0.9128065,"about_ca_system_score_codex":0.0034235062,"about_ca_system_score_gemma":0.01018865,"threshold_uncertainty_score":0.17337191},"labels":[],"label_agreement":null},{"id":"W4210298556","doi":"10.2165/00128413-200615270-00041","title":"Cipher Pharmaceuticals has received final approval from Health Canada for CIP-Fenofibrate,","year":2006,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Fenofibrate; Pharmacy; Drug approval; Pharmacology; Family medicine; Drug","score_opus":0.07076342288765271,"score_gpt":0.37455700265032493,"score_spread":0.30379357976267224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210298556","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13758968,0.079060055,0.008609698,0.048297122,0.009640648,0.004352522,0.024957621,0.0044984124,0.68299425],"genre_scores_gemma":[0.32612404,0.019257726,0.012854331,0.009384865,0.002899056,0.0006357537,0.016492287,0.0005403063,0.6118117],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99923587,0.000109959015,0.000041966785,0.00008959039,0.00038213053,0.00014059011],"domain_scores_gemma":[0.9983891,0.00026827448,0.00014531572,0.00010575372,0.00052055647,0.0005709288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011622809,0.000678036,0.0010208382,0.0011699827,0.0010049538,0.0012557864,0.0010040279,0.0025818679,0.05604867],"category_scores_gemma":[0.0020604196,0.00032855797,0.00067670294,0.00041944534,0.00067665166,0.00043142974,0.00040852945,0.0021979192,0.015046728],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012404797,0.001190323,0.0032874886,0.0013052423,0.00014642188,0.0026921602,0.0001312397,0.00078180153,0.10330044,0.007850642,0.30617732,0.56073207],"study_design_scores_gemma":[0.0059177005,0.0036211268,0.009691331,0.00019082906,0.00017882779,0.0058481274,0.000062828,0.0007559206,0.031647623,0.00053004484,0.9414977,0.0000579813],"about_ca_topic_score_codex":0.011928261,"about_ca_topic_score_gemma":0.030729758,"teacher_disagreement_score":0.98807174,"about_ca_system_score_codex":0.0020131154,"about_ca_system_score_gemma":0.006661998,"threshold_uncertainty_score":0.18750143},"labels":[],"label_agreement":null},{"id":"W4210528054","doi":"10.2165/00128413-200715730-00068","title":"A pravastatin/aspirin combination therapy [PravASA; Paladin Labs] has been launched in Canada.","year":2007,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Launched; Medicine; Pravastatin; Aspirin; Pharmacy; Family medicine; Internal medicine; Engineering","score_opus":0.032241837680085705,"score_gpt":0.2847662141551547,"score_spread":0.252524376475069,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210528054","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21641855,0.1271708,0.008580557,0.10718657,0.009677464,0.004225888,0.014480524,0.0058490327,0.50641066],"genre_scores_gemma":[0.5184692,0.053308006,0.02239476,0.030944815,0.0030369044,0.0007367734,0.011590398,0.0006511648,0.35886803],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990588,0.00009785715,0.000031179698,0.00009789225,0.0005074141,0.00020675188],"domain_scores_gemma":[0.9981212,0.00013065936,0.000075248776,0.00003573459,0.0006574463,0.0009797892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011423064,0.0004628704,0.001109203,0.0010370244,0.0020495905,0.0013463303,0.0008599153,0.0017134161,0.029427692],"category_scores_gemma":[0.0009090114,0.00021031058,0.00065493124,0.0010027636,0.00078725064,0.000311567,0.00057715306,0.0021937191,0.005164107],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067787496,0.0027217704,0.025581958,0.0009500946,0.0002479899,0.0020283388,0.0001763804,0.0002610298,0.027247816,0.0027564368,0.26672027,0.6645292],"study_design_scores_gemma":[0.004088508,0.0057452447,0.08805626,0.00034513982,0.0005006377,0.0023987321,0.00033027263,0.0010298116,0.010302906,0.0007131066,0.88638747,0.000101897116],"about_ca_topic_score_codex":0.32797322,"about_ca_topic_score_gemma":0.6409236,"teacher_disagreement_score":0.67202675,"about_ca_system_score_codex":0.0041535683,"about_ca_system_score_gemma":0.018953599,"threshold_uncertainty_score":0.6521284},"labels":[],"label_agreement":null},{"id":"W4210872218","doi":"10.2165/00128413-200514960-00047","title":"Health Canada has received four reports of Duragesic [fentanyl] patch abuse by boys aged 14???17 years, between 1 Jan 1998 and 31 Jan 2005,","year":2005,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Anesthesia and Neurotoxicity Research","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Fentanyl; Psychiatry; Family medicine; Pediatrics; Anesthesia","score_opus":0.05029089341759819,"score_gpt":0.2915990064071286,"score_spread":0.24130811298953042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210872218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95463103,0.0033298337,0.00018567167,0.0045693833,0.00051947567,0.00014558755,0.004182462,0.00009058585,0.03234592],"genre_scores_gemma":[0.9599608,0.0034749703,0.00056714134,0.003102669,0.00017671085,0.000026721871,0.0021766857,0.00003443767,0.030479845],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999303,0.000031377054,0.000059370872,0.000053226813,0.00033107089,0.00022202705],"domain_scores_gemma":[0.99763536,0.00020491335,0.0005997022,0.000042325115,0.0010076076,0.0005100826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026661513,0.0002956528,0.00031782076,0.0015377502,0.002571345,0.00075695274,0.00061499747,0.0011198849,0.0045603286],"category_scores_gemma":[0.0017225451,0.00033393456,0.00031269004,0.0012369897,0.00060114916,0.0003743575,0.0006511947,0.001179352,0.00055045966],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008274157,0.00015807844,0.9585623,0.00013021012,0.000054946046,0.0145008955,0.0018653757,0.000042035965,0.00079360197,0.00016065943,0.009331514,0.014317733],"study_design_scores_gemma":[0.000010157133,0.00018849307,0.9495979,0.00011342285,0.00006624419,0.015763815,0.0060305214,0.00006733553,0.0007957157,0.00002311077,0.027318627,0.000024694134],"about_ca_topic_score_codex":0.5857259,"about_ca_topic_score_gemma":0.8535946,"teacher_disagreement_score":0.4142741,"about_ca_system_score_codex":0.003775566,"about_ca_system_score_gemma":0.005231501,"threshold_uncertainty_score":0.83342767},"labels":[],"label_agreement":null},{"id":"W4212882070","doi":"10.2165/00128413-200715910-00071","title":"Product approvals in Canada","year":2007,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Product (mathematics); Pharmacy; Family medicine; Mathematics","score_opus":0.3321649356588049,"score_gpt":0.42406658912105033,"score_spread":0.09190165346224544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212882070","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04226076,0.025716433,0.0011621347,0.0395348,0.010242094,0.0010378546,0.034534574,0.0010109278,0.8445005],"genre_scores_gemma":[0.12024953,0.007748218,0.0008525056,0.009048986,0.00066157535,0.00018901606,0.009129057,0.00031882548,0.8518023],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99293715,0.0003547469,0.00026335174,0.00049330393,0.004722932,0.0012284819],"domain_scores_gemma":[0.9842003,0.0007403063,0.00037381647,0.00027523297,0.012328612,0.0020816878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031499881,0.0005499688,0.0007260086,0.0036562018,0.004259442,0.0053047147,0.0011771136,0.0027304655,0.056208953],"category_scores_gemma":[0.009649679,0.00050479715,0.0011162147,0.0030704236,0.0011965402,0.00065489067,0.0008476631,0.0027617062,0.010894186],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004202416,0.00010860241,0.007277981,0.0003659675,0.000045719727,0.00039180947,0.00023973844,0.00030542133,0.00087054365,0.008221804,0.9079683,0.07378393],"study_design_scores_gemma":[0.000066384644,0.000063642765,0.028831398,0.00013716299,0.000030281395,0.000078209705,0.00019211727,0.00031989283,0.00056295394,0.000277328,0.96940976,0.00003091412],"about_ca_topic_score_codex":0.952157,"about_ca_topic_score_gemma":0.9678574,"teacher_disagreement_score":0.056208953,"about_ca_system_score_codex":0.03610805,"about_ca_system_score_gemma":0.11426671,"threshold_uncertainty_score":0.26198345},"labels":[],"label_agreement":null},{"id":"W4214588361","doi":"10.2165/00128413-200113140-00012","title":"Galantamine treatment for AD warranted in Canada","year":2001,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Galantamine; Pharmacy; Psychiatry; Pharmacology; Family medicine; Internal medicine; Donepezil; Disease; Dementia","score_opus":0.05737118821012451,"score_gpt":0.33578677960604236,"score_spread":0.27841559139591787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214588361","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6296957,0.030952884,0.000877201,0.08550134,0.0015795251,0.00038489784,0.005240147,0.00031068374,0.24545759],"genre_scores_gemma":[0.93255734,0.009942197,0.001367388,0.01105117,0.00027282373,0.00004416146,0.0013002076,0.00006235306,0.043402333],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996568,0.00002313946,0.000023674465,0.000026338863,0.00010046982,0.00016959498],"domain_scores_gemma":[0.9990544,0.00004774726,0.000078552875,0.00000783462,0.0003351898,0.00047632694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000179001,0.00016538937,0.00025279095,0.0007900094,0.002609378,0.00085149705,0.0006189815,0.0007841259,0.008028732],"category_scores_gemma":[0.0010683099,0.00014138533,0.0002766069,0.001333753,0.00037125463,0.00023894712,0.0003248605,0.0012605337,0.00045916936],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018477362,0.0011734955,0.41180673,0.0009363393,0.0002697861,0.039868403,0.0016389835,0.00072418345,0.00533374,0.008680705,0.20717831,0.32054156],"study_design_scores_gemma":[0.0010083584,0.0007367697,0.634342,0.0011917034,0.00039394567,0.03167249,0.006155933,0.0023742334,0.0025394228,0.0024246206,0.31704184,0.00011862713],"about_ca_topic_score_codex":0.9572743,"about_ca_topic_score_gemma":0.99178547,"teacher_disagreement_score":0.042725682,"about_ca_system_score_codex":0.0187668,"about_ca_system_score_gemma":0.040639155,"threshold_uncertainty_score":0.1361633},"labels":[],"label_agreement":null},{"id":"W4229711811","doi":"10.2165/00128413-200515160-00042","title":"Health Canada has advised that it is reviewing if changes to the Canadian Evra [ethinylestradiol/norelgestromin] labelling are required,","year":2005,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Labelling; Medicine; Ethinylestradiol; Pharmacy; Family medicine; Environmental health; Criminology; Research methodology; Population","score_opus":0.38029838914329867,"score_gpt":0.45772187177370716,"score_spread":0.07742348263040849,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229711811","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010109012,0.0051550725,0.004450526,0.7811745,0.025970286,0.0021661874,0.0063675926,0.001844814,0.16276209],"genre_scores_gemma":[0.030708479,0.0055167894,0.02343225,0.44554812,0.002633859,0.00070494995,0.003658652,0.0005742259,0.48722267],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98215944,0.001862305,0.0016851757,0.00059663504,0.010862942,0.002833516],"domain_scores_gemma":[0.8989999,0.016954634,0.0025913091,0.001947521,0.06954174,0.0099648675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018281156,0.0006065178,0.00085148116,0.0033699467,0.0074814553,0.004057676,0.0046120933,0.017928097,0.02923614],"category_scores_gemma":[0.05254749,0.0010105439,0.0019391064,0.003348095,0.0030169925,0.0014828058,0.0012779186,0.010430153,0.007671089],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054347878,0.00010204299,0.0019026025,0.00018219362,0.000010028172,0.00016287665,0.00030025962,0.00012408219,0.00072472164,0.0011305793,0.9653419,0.029964402],"study_design_scores_gemma":[0.00004987855,0.000069213325,0.012440792,0.00029514366,0.00004459633,0.0001400085,0.00057736004,0.00019769536,0.00087941776,0.00032547768,0.98492056,0.000059783124],"about_ca_topic_score_codex":0.9319236,"about_ca_topic_score_gemma":0.958807,"teacher_disagreement_score":0.96863985,"about_ca_system_score_codex":0.03136017,"about_ca_system_score_gemma":0.22680804,"threshold_uncertainty_score":0.22753501},"labels":[],"label_agreement":null},{"id":"W4230288979","doi":"10.2165/00128413-200816200-00047","title":"New warnings for Alertec in Canada","year":2008,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Risk and Safety Analysis","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacy; Family medicine","score_opus":0.11741756444950902,"score_gpt":0.35446871489658943,"score_spread":0.23705115044708042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230288979","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.100312136,0.015010449,0.007890802,0.5006491,0.026869208,0.0005601509,0.01724555,0.0032437756,0.3282189],"genre_scores_gemma":[0.41656598,0.009467581,0.008381314,0.09201696,0.0032692407,0.00015041405,0.00658498,0.0005372129,0.46302637],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9942855,0.00024454814,0.0002557656,0.00022332816,0.00407335,0.0009175103],"domain_scores_gemma":[0.9767427,0.0023202568,0.0010014891,0.00033632104,0.016900193,0.0026990327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032658223,0.0004650171,0.00044322375,0.0023890873,0.0030635276,0.0050410456,0.0012741679,0.0048004286,0.020534487],"category_scores_gemma":[0.014892703,0.0004186021,0.00081288035,0.0020899554,0.0010424113,0.001257316,0.0010064911,0.005225928,0.0017765361],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032504206,0.0000778074,0.022099098,0.00024128576,0.000029939865,0.00063374324,0.0005178463,0.00095469056,0.00081291987,0.008780201,0.8971171,0.06841043],"study_design_scores_gemma":[0.000110482164,0.0001251076,0.080302276,0.00043580393,0.00006770885,0.0002470598,0.0012428096,0.0035578168,0.0011180864,0.0018206832,0.9108894,0.000082801],"about_ca_topic_score_codex":0.96125567,"about_ca_topic_score_gemma":0.9789645,"teacher_disagreement_score":0.03874433,"about_ca_system_score_codex":0.035902005,"about_ca_system_score_gemma":0.10288624,"threshold_uncertainty_score":0.2604885},"labels":[],"label_agreement":null},{"id":"W4230932386","doi":"10.2165/00128413-200715990-00047","title":"Health Canada has granted expanded approval of lumiracoxib [Prexige; Novartis] for the treatment of acute and chronic osteoarthritis","year":2007,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Osteoarthritis; Pharmacy; Alternative medicine; Physical therapy; Intensive care medicine; Family medicine","score_opus":0.017770540404014223,"score_gpt":0.29173642141987416,"score_spread":0.27396588101585995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230932386","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09301571,0.08717605,0.0043928702,0.13253596,0.018357085,0.0019057536,0.012528512,0.0019312148,0.6481568],"genre_scores_gemma":[0.33915147,0.029155076,0.010542473,0.054399043,0.005446843,0.0002650539,0.014279603,0.00025971024,0.54650074],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984584,0.000192586,0.0000469649,0.00008849967,0.0008248003,0.000388714],"domain_scores_gemma":[0.99560505,0.0005430181,0.00019264444,0.00008843042,0.0021680347,0.0014027598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013396714,0.000489609,0.000723569,0.0012907542,0.0017304989,0.0013835693,0.0009557947,0.0025176648,0.030552266],"category_scores_gemma":[0.0025527524,0.00030269855,0.00093704945,0.0007851869,0.0010383595,0.0002908627,0.0006834805,0.0028595305,0.004255975],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033379695,0.00085386034,0.009369525,0.00071753905,0.00018294463,0.0025166802,0.00013088486,0.00041166937,0.022564135,0.0058073653,0.6161721,0.3379353],"study_design_scores_gemma":[0.0014039673,0.0011801647,0.029763171,0.00020113174,0.00014725009,0.001728706,0.000096001124,0.0005902171,0.0038744411,0.0003372035,0.9606269,0.000050951596],"about_ca_topic_score_codex":0.30196768,"about_ca_topic_score_gemma":0.64850813,"teacher_disagreement_score":0.6980323,"about_ca_system_score_codex":0.0067660683,"about_ca_system_score_gemma":0.03423879,"threshold_uncertainty_score":0.60042006},"labels":[],"label_agreement":null},{"id":"W4231145226","doi":"10.2165/00128413-200414600-00058","title":"Product launches in Canada","year":2004,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Biotechnology and Related Fields","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacy; Product (mathematics); Family medicine","score_opus":0.00907366324514077,"score_gpt":0.2266015710834211,"score_spread":0.21752790783828033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4231145226","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.054356758,0.007092227,0.00053332024,0.028118946,0.0056302836,0.00037386658,0.01971143,0.0010682255,0.88311493],"genre_scores_gemma":[0.077062845,0.0033688473,0.00033740592,0.0034360734,0.0002707203,0.00003624471,0.0041151997,0.00015011644,0.9112225],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976787,0.000051974886,0.00004007814,0.00013436055,0.0014504672,0.000644448],"domain_scores_gemma":[0.9963558,0.00014815034,0.00010772495,0.000055305387,0.0018961001,0.0014369908],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091087545,0.00053202413,0.00037902629,0.0029487482,0.0048127226,0.0060640885,0.0007793063,0.002093672,0.08982397],"category_scores_gemma":[0.0024376034,0.00041184595,0.00064042624,0.002824134,0.0010223396,0.00089135644,0.0010129393,0.0020084106,0.013604438],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025082793,0.00013370448,0.012231503,0.00019420171,0.000021368229,0.0005415419,0.00052193063,0.00027485628,0.001111625,0.009736262,0.9151517,0.05983049],"study_design_scores_gemma":[0.000026556974,0.0000625801,0.03865286,0.000068281435,0.000014221379,0.00010168996,0.0009458373,0.00023050501,0.00071453344,0.00022159544,0.9589382,0.00002322926],"about_ca_topic_score_codex":0.9628511,"about_ca_topic_score_gemma":0.9817005,"teacher_disagreement_score":0.08982397,"about_ca_system_score_codex":0.034045856,"about_ca_system_score_gemma":0.08444771,"threshold_uncertainty_score":0.3004911},"labels":[],"label_agreement":null},{"id":"W4231537586","doi":"10.2165/00128413-200615510-00066","title":"Health Canada has approved rituximab [Rituxan; Roche] as a maintenance therapy for patients with follicular non-Hodgkin's lymphoma","year":2006,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Rituximab; Follicular lymphoma; Oncology; Lymphoma; Hodgkin lymphoma; Maintenance therapy; Internal medicine; Pharmacy; Family medicine; Chemotherapy","score_opus":0.007872528325920655,"score_gpt":0.2359594050837431,"score_spread":0.22808687675782247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4231537586","genre_codex":"other","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.303723,0.10686663,0.0069023105,0.107315965,0.0052496037,0.0023295933,0.008229656,0.0026982022,0.45668507],"genre_scores_gemma":[0.72854745,0.028595196,0.017975507,0.03731734,0.0017972087,0.00040460145,0.0069119944,0.00036040368,0.17809032],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992901,0.00014997843,0.00003195988,0.000049932176,0.00028882615,0.00018920217],"domain_scores_gemma":[0.99777466,0.0004185687,0.00016455854,0.00006202215,0.0008075729,0.00077261054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010846267,0.00027891825,0.0005473522,0.0007146945,0.0015965246,0.0009405006,0.0009765937,0.001790368,0.011310085],"category_scores_gemma":[0.0015078901,0.0002196895,0.0005922221,0.0007041989,0.0006664498,0.00020572632,0.00027971904,0.0016797547,0.0019892969],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036657013,0.0011085867,0.051368136,0.0008117294,0.00025628062,0.0027499213,0.00026693507,0.00070764753,0.026697353,0.0034013565,0.31668922,0.59227705],"study_design_scores_gemma":[0.0027256727,0.0034890473,0.08202838,0.00032784286,0.00043208245,0.003554027,0.00018848709,0.0011146312,0.0101971375,0.0003548476,0.895526,0.00006182774],"about_ca_topic_score_codex":0.3317898,"about_ca_topic_score_gemma":0.68204635,"teacher_disagreement_score":0.6682102,"about_ca_system_score_codex":0.006778314,"about_ca_system_score_gemma":0.021781323,"threshold_uncertainty_score":0.6597171},"labels":[],"label_agreement":null},{"id":"W4231741136","doi":"10.2165/00128413-200615540-00012","title":"Ezetimibe add-on to atorvastatin: evidence for adoption in Canada","year":2006,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Synthesis of β-Lactam Compounds","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ezetimibe; Atorvastatin; Medicine; Pharmacy; Pharmacology; Family medicine; Internal medicine; Statin","score_opus":0.047076522814544865,"score_gpt":0.2926426875188345,"score_spread":0.24556616470428963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4231741136","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7977946,0.088645585,0.0015069261,0.042362254,0.0008839092,0.0007018928,0.010035278,0.00016959697,0.057899974],"genre_scores_gemma":[0.9509615,0.036639992,0.0014049505,0.0051344023,0.00013231958,0.00007881731,0.0018168741,0.00006434956,0.0037668338],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99276614,0.0010824081,0.0005809501,0.0007498162,0.0039032155,0.0009174385],"domain_scores_gemma":[0.95319456,0.013221204,0.009502269,0.0011006927,0.017697705,0.005283518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048497226,0.0003290623,0.000888016,0.0018255553,0.0017450557,0.0029619627,0.002033634,0.001380373,0.0066533294],"category_scores_gemma":[0.038599055,0.0005711423,0.0010350943,0.0061725713,0.0018502508,0.0010209345,0.00097604253,0.0028140177,0.00031083266],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009857035,0.00066207425,0.4921515,0.0034971274,0.00097373285,0.00077344326,0.0031932434,0.0007535868,0.001854101,0.0058759404,0.032249864,0.44815838],"study_design_scores_gemma":[0.0022697127,0.0011593077,0.9319819,0.00279847,0.002643196,0.00038318973,0.0031004038,0.0016325901,0.0013998505,0.00063574576,0.051873825,0.00012189194],"about_ca_topic_score_codex":0.9712128,"about_ca_topic_score_gemma":0.982533,"teacher_disagreement_score":0.03480037,"about_ca_system_score_codex":0.03480037,"about_ca_system_score_gemma":0.09211115,"threshold_uncertainty_score":0.25249553},"labels":[],"label_agreement":null},{"id":"W4233017224","doi":"10.2165/00128413-200213330-00013","title":"Inappropriate pantoprazole use in Canada despite guidelines","year":2002,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pantoprazole; Pharmacy; Intensive care medicine; Internal medicine; Family medicine; Omeprazole","score_opus":0.22547757895640566,"score_gpt":0.3783929247872928,"score_spread":0.15291534583088714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233017224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83836347,0.024707668,0.00037559902,0.077044845,0.0010063084,0.00020089628,0.0061035524,0.00008628427,0.052111395],"genre_scores_gemma":[0.97871566,0.0065549817,0.00045184875,0.010697408,0.0001934186,0.000018612463,0.0007123359,0.000029534007,0.0026261318],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950724,0.00043103847,0.00054495805,0.0003291836,0.002541835,0.0010805229],"domain_scores_gemma":[0.9746926,0.0029205699,0.0046841647,0.00026817326,0.012142616,0.005291907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014530787,0.00021245504,0.00054095587,0.0019434319,0.0038251774,0.0025202709,0.0014943115,0.0018786106,0.0033177873],"category_scores_gemma":[0.018986179,0.00042903706,0.0004368623,0.006153919,0.0011939171,0.00072241836,0.0006910869,0.0032308595,0.00022086628],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042288896,0.00030696014,0.90492797,0.00052542693,0.00016696363,0.003453783,0.0026962217,0.0003521127,0.00049269444,0.0017759453,0.033291,0.051588017],"study_design_scores_gemma":[0.00010998375,0.00010936852,0.96802247,0.0007321315,0.00023030785,0.0017404272,0.0037930487,0.0014167823,0.00027703177,0.00031094273,0.02318617,0.00007134237],"about_ca_topic_score_codex":0.992428,"about_ca_topic_score_gemma":0.9964265,"teacher_disagreement_score":0.047511015,"about_ca_system_score_codex":0.047511015,"about_ca_system_score_gemma":0.11769288,"threshold_uncertainty_score":0.3447181},"labels":[],"label_agreement":null},{"id":"W4233022709","doi":"10.2165/00128413-200615320-00042","title":"Health Canada has warned consumers about counterfeit and unapproved products for avian influenza.","year":2006,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Global Public Health Policies and Epidemiology","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Counterfeit; Medicine; Influenza A virus subtype H5N1; Pharmacy; Virology; Advertising; Environmental health; Commerce; Business; Family medicine; Virus; Political science; Law","score_opus":0.04094740791769242,"score_gpt":0.2938180971714604,"score_spread":0.252870689253768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233022709","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.050733384,0.012889215,0.0013917793,0.5586826,0.008439299,0.00019451226,0.0027512081,0.0005668344,0.36435118],"genre_scores_gemma":[0.20642857,0.013495734,0.0029680398,0.25983837,0.0024961196,0.00005713751,0.0021233726,0.00021496986,0.51237774],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99689984,0.00020430682,0.000066397064,0.00011193276,0.0020783087,0.0006391921],"domain_scores_gemma":[0.9898226,0.002038407,0.00043915797,0.0002581925,0.0052872607,0.0021543596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022634713,0.00035959622,0.00029785535,0.001027059,0.0069112503,0.0033289033,0.0009875622,0.007190298,0.031858385],"category_scores_gemma":[0.007349941,0.00026917923,0.0005151898,0.001145079,0.0021121507,0.0011579351,0.0010496851,0.006846666,0.003826315],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013484871,0.00011093219,0.016665705,0.0001555718,0.00002020264,0.00041355376,0.00089354574,0.00009384815,0.001382743,0.007073702,0.8983976,0.07465775],"study_design_scores_gemma":[0.000017587961,0.000067720866,0.022624714,0.0001802698,0.000030538897,0.00022299614,0.0016981454,0.00015691503,0.0011330378,0.0006314558,0.97320276,0.000033887845],"about_ca_topic_score_codex":0.8628297,"about_ca_topic_score_gemma":0.92442626,"teacher_disagreement_score":0.13717031,"about_ca_system_score_codex":0.011115564,"about_ca_system_score_gemma":0.041074302,"threshold_uncertainty_score":0.2759562},"labels":[],"label_agreement":null},{"id":"W4233820458","doi":"10.2165/00128413-200514910-00055","title":"The Therapeutic Products Directorate of Canada has issued a Notice of Compliance for metformin","year":2005,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Notice; Medicine; Metformin; Compliance (psychology); Pharmacy; Intensive care medicine; Family medicine; Diabetes mellitus; Law; Political science; Endocrinology","score_opus":0.5281201482468323,"score_gpt":0.44061595759940797,"score_spread":0.08750419064742432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233820458","genre_codex":"other","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021683915,0.005541239,0.00555037,0.3512077,0.03665904,0.003865305,0.025525305,0.0025701402,0.54739696],"genre_scores_gemma":[0.07030563,0.0035002837,0.011758467,0.16815975,0.007270936,0.000955766,0.013439686,0.00063594134,0.72397345],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.97844267,0.0020739106,0.0017149608,0.0006892697,0.013995026,0.0030842177],"domain_scores_gemma":[0.91856045,0.01816081,0.0037943264,0.003006957,0.04833444,0.008143048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016638398,0.0005771214,0.0011997346,0.0034989668,0.005533981,0.0035990279,0.0025392782,0.013773662,0.032695983],"category_scores_gemma":[0.047616385,0.00080412003,0.001537464,0.0028919573,0.0016004246,0.000927994,0.0013147992,0.010437804,0.00793355],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026490702,0.00025537767,0.0036032647,0.00013792564,0.00002865157,0.00016280527,0.000113855574,0.000096532734,0.0006168831,0.00457391,0.95531213,0.03483375],"study_design_scores_gemma":[0.00015033458,0.00018330412,0.020129438,0.00018040788,0.000053181942,0.00013418274,0.00011996698,0.0003769365,0.00095820666,0.0004376587,0.97720736,0.00006902592],"about_ca_topic_score_codex":0.67179346,"about_ca_topic_score_gemma":0.8289697,"teacher_disagreement_score":0.32820654,"about_ca_system_score_codex":0.016391013,"about_ca_system_score_gemma":0.096693866,"threshold_uncertainty_score":0.6602788},"labels":[],"label_agreement":null},{"id":"W4234132940","doi":"10.2165/00128413-200716130-00053","title":"Biovail has launched a once-daily tramadol formulation [Ralivia] in Canada for the management of moderately severe pain","year":2007,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Pain Management and Placebo Effect","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tramadol; Medicine; Launched; Pharmacy; Physical therapy; Anesthesia; Family medicine; Analgesic; Engineering","score_opus":0.06399885725976563,"score_gpt":0.27929845342081433,"score_spread":0.2152995961610487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4234132940","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.48427442,0.07233344,0.0099140415,0.07249312,0.007260961,0.002831505,0.0051407777,0.0018833274,0.3438684],"genre_scores_gemma":[0.7915616,0.01821954,0.013709086,0.009834691,0.0012593879,0.00021145216,0.002155977,0.0003113061,0.16273695],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994386,0.000087257904,0.000019836845,0.000046501078,0.0002836295,0.00012416902],"domain_scores_gemma":[0.99788576,0.00028719963,0.0001492905,0.000044050088,0.00094162853,0.0006920591],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009810611,0.0003458874,0.00041098485,0.0007061925,0.0014688211,0.0014639643,0.00067752606,0.0014182572,0.013788451],"category_scores_gemma":[0.0015768282,0.00019999497,0.00033013918,0.00040602504,0.0010361347,0.00041148037,0.00042636957,0.0018536663,0.0012575022],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066688303,0.0024665687,0.016303498,0.0010373011,0.00019148372,0.0015591403,0.00083127024,0.00092795934,0.094467945,0.009492114,0.0861824,0.7798714],"study_design_scores_gemma":[0.0061181793,0.016699776,0.08067256,0.00086542085,0.0004295914,0.0042131697,0.00095458847,0.0039330916,0.05854213,0.0012710707,0.826091,0.00020943725],"about_ca_topic_score_codex":0.28735036,"about_ca_topic_score_gemma":0.59020084,"teacher_disagreement_score":0.71264964,"about_ca_system_score_codex":0.0046358043,"about_ca_system_score_gemma":0.017409401,"threshold_uncertainty_score":0.5713556},"labels":[],"label_agreement":null},{"id":"W4234456851","doi":"10.2165/00128413-200716160-00066","title":"Health Canada has approved anidulafungin [Eraxis; Pfizer].","year":2007,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Anidulafungin; Pharmacy; Family medicine; Dermatology","score_opus":0.024275278019914956,"score_gpt":0.3019655304416766,"score_spread":0.27769025242176165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4234456851","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.053891104,0.13941069,0.007112151,0.119110174,0.011244731,0.0018869025,0.013449802,0.0038488018,0.65004563],"genre_scores_gemma":[0.32903415,0.06756892,0.015192939,0.03910198,0.0024393566,0.00037117588,0.0108946515,0.00037584032,0.53502095],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99911433,0.00011254273,0.000032488995,0.00006757843,0.00049832184,0.00017473185],"domain_scores_gemma":[0.99883944,0.00018634577,0.0000840722,0.000034281966,0.00046339526,0.00039243736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006220393,0.0004425727,0.0007510286,0.0008677937,0.0014057644,0.0009534677,0.00089871103,0.002292171,0.05001401],"category_scores_gemma":[0.0015960285,0.00019290227,0.0007053441,0.0006832428,0.000582456,0.00031854573,0.0003805687,0.0020964704,0.007967628],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022089481,0.00084745133,0.0044969614,0.0008333434,0.000094809664,0.0015259478,0.00006319391,0.00030856152,0.013617233,0.0033251918,0.5512203,0.42145798],"study_design_scores_gemma":[0.0010119679,0.0009990117,0.0077314298,0.0003054504,0.00012551558,0.0023705151,0.000104004284,0.0008494778,0.0058496557,0.00067372445,0.9799415,0.000037788534],"about_ca_topic_score_codex":0.1629806,"about_ca_topic_score_gemma":0.39563134,"teacher_disagreement_score":0.8370194,"about_ca_system_score_codex":0.0030186453,"about_ca_system_score_gemma":0.011851668,"threshold_uncertainty_score":0.3240639},"labels":[],"label_agreement":null},{"id":"W4234589576","doi":"10.2165/00128413-200414430-00058","title":"The dermatology unit of Aventis Pharma has launched a benzoyl peroxide/clindamycin [BenzaClin] topical gel in Canada","year":2004,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Benzoyl peroxide; Medicine; Dermatology; Pharmacy; Clindamycin; Launched; Family medicine; Organic chemistry; Chemistry; Engineering; Antibiotics","score_opus":0.03369672348768448,"score_gpt":0.30097069412356364,"score_spread":0.26727397063587915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4234589576","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22894056,0.08105046,0.008320043,0.13195731,0.018073868,0.0018157884,0.003507062,0.0031486591,0.5231863],"genre_scores_gemma":[0.32349226,0.014097513,0.010463921,0.010688336,0.0018383509,0.0000747045,0.0010944201,0.00033446963,0.637916],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988181,0.000121066,0.00003704946,0.00011547264,0.00064213807,0.00026612825],"domain_scores_gemma":[0.99670273,0.00030082944,0.00018411744,0.00006818033,0.0013616767,0.001382466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011488468,0.0004798099,0.00037088885,0.0009793806,0.0024166142,0.0013875788,0.00054815103,0.0016993282,0.06216899],"category_scores_gemma":[0.0011065133,0.00028244682,0.00053274975,0.00039292107,0.0008617497,0.0004457635,0.0005075843,0.0017037839,0.006573227],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018372395,0.0016479151,0.021221995,0.0008181838,0.00008799846,0.0031454684,0.00037250464,0.00043793372,0.24753399,0.0048422585,0.2823844,0.43567017],"study_design_scores_gemma":[0.0005120742,0.0029557028,0.045840133,0.0002151859,0.00009145636,0.0031545418,0.0004524977,0.0011186306,0.06365383,0.0002991646,0.88165206,0.0000548012],"about_ca_topic_score_codex":0.14049402,"about_ca_topic_score_gemma":0.40139568,"teacher_disagreement_score":0.859506,"about_ca_system_score_codex":0.0045558107,"about_ca_system_score_gemma":0.011097119,"threshold_uncertainty_score":0.2793525},"labels":[],"label_agreement":null},{"id":"W4235394295","doi":"10.2165/00128413-200313800-00057","title":"Market news from Canada","year":2003,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Legal case studies and regulations","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacy; Advertising; Family medicine; Business","score_opus":0.01773726546594473,"score_gpt":0.27778242356339683,"score_spread":0.2600451580974521,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4235394295","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0029096487,0.015304957,0.00021600505,0.10338954,0.021210631,0.00010167785,0.009780852,0.0005683317,0.8465184],"genre_scores_gemma":[0.0049713133,0.0021599066,0.00007351571,0.006423747,0.00064896786,0.000014078019,0.0010531836,0.0000764441,0.98457885],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981567,0.00004662703,0.00003547204,0.00012704577,0.0011796936,0.00045452212],"domain_scores_gemma":[0.9972351,0.00019456433,0.00007265625,0.00011247169,0.0018417628,0.0005434869],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009962037,0.0008076721,0.00073899596,0.0021883764,0.006270333,0.011428613,0.0010514822,0.005041019,0.18927272],"category_scores_gemma":[0.0031161667,0.0005199396,0.00065070705,0.0033279904,0.0010014337,0.0015369377,0.0010223624,0.003856556,0.05606619],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012897841,0.000005246414,0.000108923814,0.0000189671,0.0000012183646,0.000023435761,0.00002243397,0.00001285876,0.000028503197,0.0012000586,0.993933,0.0046324376],"study_design_scores_gemma":[0.0000056633935,0.0000033362917,0.001217954,0.000032306874,0.0000025106722,0.000010011801,0.00010525908,0.000025450503,0.000054539927,0.00016248146,0.9983748,0.0000055929413],"about_ca_topic_score_codex":0.85448825,"about_ca_topic_score_gemma":0.9438511,"teacher_disagreement_score":0.18927272,"about_ca_system_score_codex":0.02076567,"about_ca_system_score_gemma":0.040396627,"threshold_uncertainty_score":0.6331803},"labels":[],"label_agreement":null},{"id":"W4236537247","doi":"10.2165/00128413-200313780-00008","title":"Statin therapy cost saving for prevention of CVD in Canada","year":2003,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacy; Intensive care medicine; Family medicine","score_opus":0.03379908012347198,"score_gpt":0.31107448877685345,"score_spread":0.27727540865338146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4236537247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80901563,0.025866536,0.0006206023,0.087499835,0.0010521241,0.00031877894,0.022356112,0.0001866518,0.05308379],"genre_scores_gemma":[0.9718759,0.008060934,0.0010491965,0.004405687,0.0003015804,0.000047540027,0.0026527348,0.000033399818,0.011572987],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983546,0.00016332438,0.00011213951,0.00009051668,0.0007393529,0.0005400379],"domain_scores_gemma":[0.9965258,0.00036173518,0.0003757396,0.000049979495,0.0011408732,0.0015458415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000661572,0.00028434032,0.00060933543,0.0016100324,0.0017534832,0.0020620143,0.0010967965,0.0012374423,0.006999635],"category_scores_gemma":[0.0055303425,0.00043737487,0.0010525831,0.0030993859,0.00052604114,0.0004680411,0.0005981634,0.0013486505,0.00022608445],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054269326,0.0008274796,0.58245265,0.0012820018,0.0015523819,0.0019902426,0.0006412678,0.012976022,0.0014999339,0.014062662,0.15701546,0.22027294],"study_design_scores_gemma":[0.001170638,0.0003522292,0.941807,0.00047302473,0.001338846,0.00083443953,0.0008861355,0.010825506,0.0005209563,0.001141449,0.040549938,0.000099802164],"about_ca_topic_score_codex":0.994121,"about_ca_topic_score_gemma":0.9968694,"teacher_disagreement_score":0.07384063,"about_ca_system_score_codex":0.07384063,"about_ca_system_score_gemma":0.15895483,"threshold_uncertainty_score":0.5357538},"labels":[],"label_agreement":null},{"id":"W4237312607","doi":"10.2165/00128413-200514930-00064","title":"Health Canada has approved a new indication for candesartan cilexetil","year":2005,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Cardiac, Anesthesia and Surgical Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Candesartan; Medicine; Pharmacy; Intensive care medicine; Family medicine; Internal medicine; Angiotensin II; Receptor","score_opus":0.03292257216751831,"score_gpt":0.2989812046243451,"score_spread":0.26605863245682676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237312607","genre_codex":"other","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.084392644,0.05326143,0.0066553806,0.264519,0.030351985,0.0013087686,0.011430796,0.0035079906,0.544572],"genre_scores_gemma":[0.3046022,0.029049022,0.017993549,0.17758416,0.017616149,0.0003945589,0.0147572495,0.0006274364,0.43737575],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99822515,0.00015423991,0.00009836378,0.00012044176,0.0009716808,0.00043001858],"domain_scores_gemma":[0.99184376,0.0016027892,0.000498996,0.00020236135,0.0024963843,0.0033558179],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015421205,0.00041819227,0.0009709306,0.0014480575,0.0018614331,0.0025989383,0.0009872076,0.0027117454,0.022170888],"category_scores_gemma":[0.004703006,0.00030552948,0.0012083534,0.0010723318,0.0009190395,0.0004081001,0.0005780821,0.0053917076,0.0047959043],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023781739,0.00090645556,0.01413914,0.0003657192,0.00013205764,0.001323785,0.000096309195,0.0001435419,0.004913231,0.0026997577,0.7433354,0.22956643],"study_design_scores_gemma":[0.0018128115,0.0008754549,0.041706428,0.00027921828,0.0002735163,0.0011131748,0.00010802794,0.00069396925,0.0020987939,0.0005470506,0.9504149,0.00007664347],"about_ca_topic_score_codex":0.25669816,"about_ca_topic_score_gemma":0.5429542,"teacher_disagreement_score":0.9918395,"about_ca_system_score_codex":0.008160462,"about_ca_system_score_gemma":0.033850897,"threshold_uncertainty_score":0.51040804},"labels":[],"label_agreement":null},{"id":"W4237317969","doi":"10.2165/00128413-200213670-00047","title":"Market news from Canada","year":2002,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Legal case studies and regulations","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacy; Family medicine","score_opus":0.0267519930970027,"score_gpt":0.2678704925917876,"score_spread":0.24111849949478487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237317969","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028513968,0.015291443,0.00020707608,0.10104848,0.022673033,0.00010000317,0.0095900195,0.0005610946,0.84767747],"genre_scores_gemma":[0.0045150197,0.0019480329,0.000065214146,0.006009185,0.0006518285,0.000013034264,0.0010517827,0.00006992629,0.98567605],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980914,0.000049349193,0.000035770383,0.00013203785,0.0012210708,0.0004702395],"domain_scores_gemma":[0.9972236,0.00018608726,0.00006988282,0.00010895672,0.0018684403,0.00054298923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009695478,0.0008633199,0.0007448778,0.0022559403,0.0062602307,0.011893647,0.0010375709,0.005136615,0.1923435],"category_scores_gemma":[0.0031041277,0.00054473407,0.0006300621,0.0032568504,0.00096823374,0.0015944161,0.0010527546,0.003828735,0.057515215],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013081176,0.000005525581,0.00010607992,0.00001932863,0.0000012670835,0.000022940363,0.000021342228,0.000013461351,0.000029241835,0.0011656985,0.99395764,0.004644372],"study_design_scores_gemma":[0.000005681676,0.0000034333043,0.0012051332,0.00003127826,0.000002432259,0.000009212408,0.00009975414,0.000025542162,0.00005197637,0.00014564837,0.9984144,0.000005561632],"about_ca_topic_score_codex":0.8415428,"about_ca_topic_score_gemma":0.939283,"teacher_disagreement_score":0.1923435,"about_ca_system_score_codex":0.01985699,"about_ca_system_score_gemma":0.03759716,"threshold_uncertainty_score":0.6434531},"labels":[],"label_agreement":null},{"id":"W4237480749","doi":"10.2165/00128413-200514870-00042","title":"Health Canada has approved pegaptanib","year":2005,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Cardiac, Anesthesia and Surgical Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pegaptanib; Pharmacy; Family medicine; Internal medicine; Bevacizumab; Ranibizumab","score_opus":0.025213595208605114,"score_gpt":0.27756608690151513,"score_spread":0.25235249169291,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237480749","genre_codex":"other","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13055158,0.032606702,0.0046802163,0.23711833,0.012561734,0.0013996231,0.005926332,0.0022704555,0.57288504],"genre_scores_gemma":[0.532718,0.012690369,0.0078143105,0.08230088,0.0028547668,0.00031633503,0.0054211933,0.0002596392,0.35562447],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99907124,0.00013627192,0.00005360836,0.000076045915,0.00040938205,0.00025348904],"domain_scores_gemma":[0.9978631,0.00041649753,0.00018756987,0.00007525371,0.0006876238,0.0007699354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008004645,0.00030871812,0.00048682748,0.0006941024,0.0013418864,0.0013708711,0.0007151391,0.0024311037,0.018874366],"category_scores_gemma":[0.00266278,0.00021239102,0.00066855224,0.00057614996,0.00074685377,0.00031416529,0.00045157055,0.0025240735,0.004239227],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038309859,0.001231057,0.024690105,0.00046378703,0.00021238659,0.0028330516,0.00013204587,0.0005016675,0.009507255,0.006261316,0.4901907,0.4601457],"study_design_scores_gemma":[0.0021604756,0.0013030347,0.02598919,0.00021025512,0.00016801732,0.00254165,0.00011728671,0.00092692324,0.00709336,0.00085506093,0.95858926,0.000045483783],"about_ca_topic_score_codex":0.14217669,"about_ca_topic_score_gemma":0.30049834,"teacher_disagreement_score":0.8578233,"about_ca_system_score_codex":0.0073766694,"about_ca_system_score_gemma":0.01865073,"threshold_uncertainty_score":0.28269827},"labels":[],"label_agreement":null},{"id":"W4237810388","doi":"10.2165/00128413-200615410-00053","title":"Health Canada has approved Pfizer's sunitinib for the treatment of gastrointestinal stromal tumour","year":2006,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Sunitinib; GiST; Pharmacy; Imatinib; Stromal cell; Internal medicine; Oncology; Intensive care medicine; Family medicine; Cancer","score_opus":0.05069886737319331,"score_gpt":0.3131519381821563,"score_spread":0.262453070808963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237810388","genre_codex":"other","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16411123,0.15815848,0.0057397448,0.19541161,0.01563362,0.0017944007,0.0107550295,0.0031660765,0.44522983],"genre_scores_gemma":[0.57371813,0.04385421,0.010844989,0.033039186,0.003896748,0.00029191485,0.008915909,0.0004039489,0.32503498],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99926215,0.00010128118,0.000028514782,0.00006218693,0.00033413214,0.00021180093],"domain_scores_gemma":[0.998621,0.00024639428,0.00009705677,0.00003325552,0.0003658559,0.0006365251],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009221736,0.00043292195,0.0010488809,0.00088370155,0.0014712533,0.0010546267,0.00072344695,0.0023833956,0.01853276],"category_scores_gemma":[0.0011788629,0.00022562986,0.0009304353,0.0006552581,0.0007042338,0.0003579736,0.00035273138,0.0020725876,0.0032723492],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039430275,0.0009921408,0.011228955,0.0008266186,0.0002276719,0.0025275128,0.00014221287,0.0007195635,0.019460952,0.00426132,0.46163526,0.4940348],"study_design_scores_gemma":[0.003345393,0.004033718,0.032212272,0.00019024417,0.00026674278,0.004118288,0.00014905974,0.0012711589,0.008880025,0.0005928559,0.9448665,0.00007390548],"about_ca_topic_score_codex":0.16359745,"about_ca_topic_score_gemma":0.5096815,"teacher_disagreement_score":0.83640254,"about_ca_system_score_codex":0.005490404,"about_ca_system_score_gemma":0.014333142,"threshold_uncertainty_score":0.32529044},"labels":[],"label_agreement":null},{"id":"W4238567827","doi":"10.2165/00128413-200514860-00055","title":"Nicotinic acid [niacin] extended-release tablets [Niaspan] have been launched in Canada","year":2005,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Niacin; Medicine; Launched; Pharmacy; Pharmacology; Nicotinic agonist; Family medicine; Internal medicine; Engineering","score_opus":0.04005818013570484,"score_gpt":0.3366964691176261,"score_spread":0.29663828898192124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238567827","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.30532765,0.0666991,0.0029099963,0.063920416,0.00375749,0.0016289814,0.017669134,0.001214629,0.53687257],"genre_scores_gemma":[0.53692895,0.022439437,0.0070692827,0.010263106,0.00034536835,0.00013699968,0.0051198774,0.00012467027,0.41757235],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99947006,0.00004576251,0.000023254586,0.000044927187,0.00027994387,0.00013606808],"domain_scores_gemma":[0.99794453,0.00012023233,0.000098552344,0.000029764074,0.0012425429,0.0005643892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061145774,0.00023468406,0.00035122895,0.00036730355,0.0017061236,0.0012534042,0.00053879025,0.0007479125,0.020526484],"category_scores_gemma":[0.0014240226,0.00014476143,0.00025332102,0.0005267491,0.0005786416,0.00024239549,0.00046998725,0.0010891944,0.0022261592],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051393933,0.0006835025,0.052532133,0.0011199648,0.0001252167,0.0013366418,0.0006956772,0.00039804258,0.017539654,0.010142785,0.30586544,0.60442156],"study_design_scores_gemma":[0.00041918704,0.0007591416,0.10383609,0.00020633826,0.00007019141,0.0005382237,0.0005712388,0.00033539117,0.00616623,0.0002718579,0.8867884,0.000037636164],"about_ca_topic_score_codex":0.851633,"about_ca_topic_score_gemma":0.94855875,"teacher_disagreement_score":0.14836699,"about_ca_system_score_codex":0.009695959,"about_ca_system_score_gemma":0.037911672,"threshold_uncertainty_score":0.29848146},"labels":[],"label_agreement":null},{"id":"W4238956926","doi":"10.2165/00128413-200012510-00053","title":"ADR updates from Canada","year":2000,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacy; Family medicine","score_opus":0.23416960925826763,"score_gpt":0.3901204614675273,"score_spread":0.1559508522092597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238956926","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013380884,0.016392931,0.0005436301,0.033858676,0.04524566,0.00051894085,0.08646666,0.0020407597,0.81359464],"genre_scores_gemma":[0.0014640603,0.0030441463,0.00031344985,0.0025772608,0.001177689,0.000057446083,0.008472721,0.00019762664,0.98269546],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99797577,0.00008037303,0.00008916172,0.0001279793,0.0013974773,0.0003292812],"domain_scores_gemma":[0.98979235,0.00032703645,0.00016780538,0.00033608236,0.008345011,0.001031698],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017598204,0.0011177203,0.0013233854,0.0052266,0.0026877513,0.0051548597,0.0018131714,0.002309315,0.39203188],"category_scores_gemma":[0.005262387,0.00064571446,0.0009048803,0.0059796413,0.00059501023,0.0011620711,0.0011546423,0.0020955158,0.2244582],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010122712,0.0000064067176,0.00009414342,0.000027690101,9.1800825e-7,0.000008055213,0.0000041919266,0.000013656914,0.0000126253535,0.0001053297,0.990311,0.009405827],"study_design_scores_gemma":[0.000008278541,0.0000035341486,0.0012661736,0.000042835465,0.0000027709127,0.000010030322,0.000020101868,0.000026804011,0.000030362875,0.00006544223,0.99851865,0.000004979283],"about_ca_topic_score_codex":0.78496313,"about_ca_topic_score_gemma":0.8876907,"teacher_disagreement_score":0.39203188,"about_ca_system_score_codex":0.010897855,"about_ca_system_score_gemma":0.035258614,"threshold_uncertainty_score":0.86719275},"labels":[],"label_agreement":null},{"id":"W4239001268","doi":"10.2165/00128413-200113090-00057","title":"Market news from Canada","year":2001,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Legal case studies and regulations","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacy; Advertising; Family medicine; Business","score_opus":0.020230963541874824,"score_gpt":0.28726694644531486,"score_spread":0.26703598290344005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239001268","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028468105,0.015593983,0.00020473942,0.10364455,0.022729037,0.00010225433,0.009752302,0.00053406466,0.8445922],"genre_scores_gemma":[0.0044711763,0.0020446868,0.00006449746,0.0058745914,0.000665316,0.0000134016755,0.0010883237,0.00006946974,0.9857085],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99806124,0.000049794162,0.000037085985,0.00013342776,0.0012358476,0.00048252678],"domain_scores_gemma":[0.9971848,0.00020419789,0.00007535526,0.00011283687,0.0018632296,0.0005595318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010100612,0.0008728373,0.0007528544,0.0023084942,0.006336105,0.011946405,0.0010460479,0.005261838,0.19645621],"category_scores_gemma":[0.0032342658,0.00055373815,0.00064590067,0.0033203713,0.0010082321,0.001633372,0.0010769377,0.0039574048,0.059215907],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000130374165,0.000005345266,0.00010825197,0.000020343627,0.0000012468402,0.000023191025,0.000021215828,0.000013812646,0.000027484715,0.0011922189,0.9938869,0.0046868813],"study_design_scores_gemma":[0.0000055891837,0.0000033863728,0.0012292847,0.000033030276,0.000002409354,0.000009204431,0.00009893017,0.000024707906,0.000049360395,0.00014924766,0.99838936,0.0000055431924],"about_ca_topic_score_codex":0.83816797,"about_ca_topic_score_gemma":0.93746054,"teacher_disagreement_score":0.19645621,"about_ca_system_score_codex":0.020344596,"about_ca_system_score_gemma":0.038149692,"threshold_uncertainty_score":0.6572115},"labels":[],"label_agreement":null},{"id":"W4239471540","doi":"10.2165/00128413-200816250-00072","title":"Rivastigmine patch [Exelon; Novartis] for treating Alzheimer's disease (AD) is now available for use in Canada.","year":2008,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Cholinesterase and Neurodegenerative Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rivastigmine; Medicine; Disease; Pharmacy; Donepezil; Psychiatry; Dementia; Internal medicine; Family medicine","score_opus":0.09349327494708429,"score_gpt":0.3079675040132965,"score_spread":0.2144742290662122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239471540","genre_codex":"other","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2106883,0.21280554,0.009937221,0.020570617,0.004454782,0.0013989931,0.009002457,0.0048973663,0.52624476],"genre_scores_gemma":[0.65903383,0.06884452,0.009681591,0.0063042673,0.0011153712,0.00025055296,0.007759415,0.0003577629,0.24665272],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998167,0.000027129392,0.000014109458,0.00002080396,0.000070412396,0.00005090838],"domain_scores_gemma":[0.9997429,0.00002781634,0.000029120596,0.000012959779,0.00007632512,0.00011097976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003076548,0.00036423586,0.0006755016,0.00044782675,0.00059033104,0.00053540786,0.0005326203,0.00062484294,0.024164552],"category_scores_gemma":[0.0005923759,0.000099339646,0.0002689458,0.0003840044,0.00026818787,0.0002774897,0.00025488393,0.0009017083,0.007899802],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007429657,0.00087780587,0.0044770474,0.0011447711,0.00017399025,0.0019699486,0.00006843728,0.00022307408,0.048394185,0.0011488637,0.20176873,0.7323235],"study_design_scores_gemma":[0.0050964006,0.0051545133,0.073430456,0.00039622126,0.00045530367,0.0147979,0.00018743442,0.0011577404,0.028916007,0.0011323331,0.8691792,0.00009653037],"about_ca_topic_score_codex":0.038704753,"about_ca_topic_score_gemma":0.089566074,"teacher_disagreement_score":0.96129525,"about_ca_system_score_codex":0.0011690535,"about_ca_system_score_gemma":0.0022222118,"threshold_uncertainty_score":0.0808385},"labels":[],"label_agreement":null},{"id":"W4239531242","doi":"10.2165/00128413-200414290-00064","title":"The Therapeutic Products Directorate of Health Canada has approved gemifloxacin","year":2004,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Gemifloxacin; Medicine; Pharmacy; Environmental health; Family medicine; Moxifloxacin; Microbiology; Antibiotics","score_opus":0.39394233230825226,"score_gpt":0.4025350128563726,"score_spread":0.008592680548120346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239531242","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08570343,0.05670136,0.008140403,0.36179107,0.01697405,0.0029647893,0.025340054,0.0022470476,0.44013783],"genre_scores_gemma":[0.31972688,0.021478007,0.011978865,0.06577463,0.004259257,0.00030357696,0.011388917,0.00035992704,0.5647299],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.996687,0.00081360043,0.00016841537,0.0001495448,0.0015365392,0.0006450276],"domain_scores_gemma":[0.9835141,0.0020746612,0.0010631933,0.00035285015,0.010356986,0.0026382431],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045799837,0.0004391793,0.0007143231,0.0015340281,0.0016607651,0.0019756106,0.0012085204,0.0039646514,0.01986388],"category_scores_gemma":[0.009384239,0.00036273964,0.0010045575,0.0011825806,0.0009396999,0.00045177486,0.00040711198,0.0029626386,0.0037950163],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030651456,0.00047779077,0.014879055,0.0007161547,0.00012169781,0.0008844021,0.000117478805,0.00050456054,0.0089171855,0.0045439107,0.7331522,0.23262043],"study_design_scores_gemma":[0.0006778891,0.0010052948,0.018260745,0.00024698058,0.0001523758,0.00060809066,0.00012408945,0.0007503233,0.006600969,0.00026939655,0.9712625,0.000041278134],"about_ca_topic_score_codex":0.43224233,"about_ca_topic_score_gemma":0.69648296,"teacher_disagreement_score":0.988262,"about_ca_system_score_codex":0.011738012,"about_ca_system_score_gemma":0.05123117,"threshold_uncertainty_score":0.85945284},"labels":[],"label_agreement":null},{"id":"W4239662282","doi":"10.2165/00128413-200716170-00054","title":"Product approvals in Canada","year":2007,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Product (mathematics); Pharmacy; Family medicine","score_opus":0.3321649356588049,"score_gpt":0.42406658912105033,"score_spread":0.09190165346224544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239662282","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04226076,0.025716433,0.0011621347,0.0395348,0.010242094,0.0010378546,0.034534574,0.0010109278,0.8445005],"genre_scores_gemma":[0.12024953,0.007748218,0.0008525056,0.009048986,0.00066157535,0.00018901606,0.009129057,0.00031882548,0.8518023],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99293715,0.0003547469,0.00026335174,0.00049330393,0.004722932,0.0012284819],"domain_scores_gemma":[0.9842003,0.0007403063,0.00037381647,0.00027523297,0.012328612,0.0020816878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031499881,0.0005499688,0.0007260086,0.0036562018,0.004259442,0.0053047147,0.0011771136,0.0027304655,0.056208953],"category_scores_gemma":[0.009649679,0.00050479715,0.0011162147,0.0030704236,0.0011965402,0.00065489067,0.0008476631,0.0027617062,0.010894186],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004202416,0.00010860241,0.007277981,0.0003659675,0.000045719727,0.00039180947,0.00023973844,0.00030542133,0.00087054365,0.008221804,0.9079683,0.07378393],"study_design_scores_gemma":[0.000066384644,0.000063642765,0.028831398,0.00013716299,0.000030281395,0.000078209705,0.00019211727,0.00031989283,0.00056295394,0.000277328,0.96940976,0.00003091412],"about_ca_topic_score_codex":0.952157,"about_ca_topic_score_gemma":0.9678574,"teacher_disagreement_score":0.056208953,"about_ca_system_score_codex":0.03610805,"about_ca_system_score_gemma":0.11426671,"threshold_uncertainty_score":0.26198345},"labels":[],"label_agreement":null},{"id":"W4239700607","doi":"10.2165/00128413-200816490-00061","title":"Idebenone approved in Canada, but EU needs more data","year":2008,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacy; Idebenone; Family medicine; Pharmacology","score_opus":0.5159014374493767,"score_gpt":0.4176488603409993,"score_spread":0.09825257710837737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239700607","genre_codex":"other","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07606115,0.16509736,0.0069836727,0.24505766,0.020851405,0.0027550298,0.13994853,0.001311564,0.3419337],"genre_scores_gemma":[0.43584555,0.10382322,0.017950445,0.16217473,0.0040905783,0.0023131748,0.09608097,0.00087844563,0.17684291],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964515,0.00096021866,0.00036330093,0.00038940605,0.0011253116,0.000710363],"domain_scores_gemma":[0.9912493,0.0009376616,0.00086104916,0.0003993633,0.0051546358,0.0013978773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0057936567,0.00081274525,0.0023478956,0.0011928958,0.0011759967,0.0036008218,0.0016591824,0.0037620508,0.015347028],"category_scores_gemma":[0.0062442203,0.00040995752,0.0017628605,0.0022893362,0.0011212779,0.0011522021,0.00065908424,0.0044377935,0.0033506576],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018055955,0.0006684948,0.012063837,0.0030976161,0.0009376176,0.00089526264,0.000120889454,0.001471995,0.007319276,0.0078044063,0.5737917,0.3737731],"study_design_scores_gemma":[0.007010724,0.002829176,0.025098199,0.002206425,0.0010099428,0.0004983228,0.00019821593,0.00048849196,0.0061662137,0.0022747784,0.9520924,0.00012716827],"about_ca_topic_score_codex":0.38893807,"about_ca_topic_score_gemma":0.55717736,"teacher_disagreement_score":0.61106193,"about_ca_system_score_codex":0.011728064,"about_ca_system_score_gemma":0.044548962,"threshold_uncertainty_score":0.7733484},"labels":[],"label_agreement":null},{"id":"W4240112120","doi":"10.2165/00128413-200615420-00058","title":"Health Canada is warning against the use of the Triaminic Vapour Patch, which contains camphor, eucalyptus oil and menthol,","year":2006,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Drug-Induced Hepatotoxicity and Protection","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Menthol; Camphor; Medicine; Eucalyptus oil; Eucalyptus; Pharmacy; Traditional medicine; Environmental health; Toxicology; Botany; Organic chemistry; Family medicine; Biology; Chemistry","score_opus":0.13088043866062968,"score_gpt":0.3714705709660939,"score_spread":0.24059013230546425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240112120","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06575844,0.02487512,0.0048711565,0.69663405,0.020449154,0.0003173701,0.0037973092,0.0019178712,0.18137957],"genre_scores_gemma":[0.18255144,0.017131811,0.011748373,0.41991675,0.0053616147,0.000079967016,0.0022438474,0.00030195015,0.36066428],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99921334,0.00005335534,0.000035329616,0.00003083597,0.00056129653,0.00010575516],"domain_scores_gemma":[0.99776864,0.0005297436,0.00016856196,0.00006564088,0.00090351515,0.00056390505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065973506,0.00028035796,0.00038449894,0.00061465555,0.002336665,0.0006055633,0.0008441226,0.005278151,0.0109087825],"category_scores_gemma":[0.0019816293,0.00024897768,0.0006141584,0.0005829325,0.0009550214,0.00026272383,0.00031443735,0.004682176,0.0019614394],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037629047,0.00019996571,0.008026202,0.0002916312,0.000041943276,0.0030178074,0.00027781134,0.00012753966,0.015881548,0.003322521,0.8490548,0.1193819],"study_design_scores_gemma":[0.000079233694,0.00027411606,0.02103678,0.00015782301,0.00005443212,0.0015744576,0.00022861877,0.00018171071,0.0027692753,0.0003426438,0.973265,0.000035893507],"about_ca_topic_score_codex":0.5230924,"about_ca_topic_score_gemma":0.80748564,"teacher_disagreement_score":0.4769076,"about_ca_system_score_codex":0.003207323,"about_ca_system_score_gemma":0.014494619,"threshold_uncertainty_score":0.9594324},"labels":[],"label_agreement":null},{"id":"W4240272195","doi":"10.2165/00128413-200213470-00011","title":"IV heparin use higher among US vs Canadian neurologists","year":2002,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacy; Heparin; Family medicine; Internal medicine","score_opus":0.04457635898650299,"score_gpt":0.25686082834952967,"score_spread":0.2122844693630267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240272195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9710028,0.0026845972,0.00011768409,0.002745785,0.00017357981,0.00003375113,0.003238928,0.000031586736,0.019971265],"genre_scores_gemma":[0.9941386,0.0006269955,0.00010480965,0.00081798056,0.00004672083,0.000007751944,0.001068509,0.000012335205,0.0031762638],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99912876,0.000059454058,0.00006332679,0.00010919476,0.00030462767,0.0003345642],"domain_scores_gemma":[0.9977683,0.00028716557,0.00052287837,0.000052571864,0.00075780303,0.0006113714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026057122,0.00029370503,0.000529029,0.001305317,0.0014694589,0.0014833396,0.00054923806,0.0011172296,0.013068374],"category_scores_gemma":[0.0042364625,0.000279794,0.0007726504,0.0021504886,0.00030639317,0.000510489,0.000332603,0.0012335347,0.00050822675],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028157278,0.000058617992,0.98509175,0.00003641566,0.000101989106,0.00031586725,0.00036805405,0.000047984628,0.0002856716,0.0001383105,0.005606377,0.0076673958],"study_design_scores_gemma":[0.000022355405,0.000025881061,0.996842,0.000037639882,0.000064358486,0.0005407674,0.00078280404,0.00009247396,0.000060551356,0.00003608831,0.0014858192,0.000009378238],"about_ca_topic_score_codex":0.836715,"about_ca_topic_score_gemma":0.8784088,"teacher_disagreement_score":0.16328502,"about_ca_system_score_codex":0.0044290153,"about_ca_system_score_gemma":0.0065293442,"threshold_uncertainty_score":0.32849324},"labels":[],"label_agreement":null},{"id":"W4241129018","doi":"10.2165/00128413-200012260-00049","title":"Ropinirole: sudden onset of sleep warning issued in Canada","year":2000,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Sleep and related disorders","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ropinirole; Medicine; Sleep (system call); Pharmacy; Psychiatry; Internal medicine; Family medicine; Agonist","score_opus":0.009307827362471868,"score_gpt":0.2671578414079682,"score_spread":0.25785001404549635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241129018","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8135591,0.0060953447,0.0008389367,0.06571614,0.0031198326,0.0007539663,0.008367546,0.0005081874,0.1010409],"genre_scores_gemma":[0.9317851,0.0027371775,0.0006136804,0.012238496,0.0007284358,0.000034989254,0.0019150638,0.000081987295,0.049864963],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.999607,0.000014712513,0.000030147088,0.00002771002,0.00017437874,0.00014604974],"domain_scores_gemma":[0.998444,0.00009810333,0.0001519796,0.000015031295,0.0006877679,0.00060310477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023051068,0.00027909863,0.00033674776,0.0009364835,0.0032947124,0.0009997536,0.0006014695,0.0022721966,0.004965985],"category_scores_gemma":[0.0016058405,0.00023107002,0.00024337319,0.0008957859,0.0005125773,0.00026402454,0.00045441661,0.002545185,0.0006072471],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034378674,0.0011125775,0.4704766,0.0004929649,0.00020932403,0.17414854,0.0022490765,0.0007973824,0.013247842,0.0023904222,0.22694044,0.10449693],"study_design_scores_gemma":[0.0005244957,0.0010276613,0.82813996,0.00024377086,0.0001649543,0.024037758,0.0038458018,0.0024090705,0.002847536,0.00050039624,0.13610125,0.00015728106],"about_ca_topic_score_codex":0.9315798,"about_ca_topic_score_gemma":0.9715793,"teacher_disagreement_score":0.06842017,"about_ca_system_score_codex":0.013198026,"about_ca_system_score_gemma":0.026779832,"threshold_uncertainty_score":0.1376462},"labels":[],"label_agreement":null},{"id":"W4241365950","doi":"10.2165/00128413-200514760-00056","title":"Ethinylestradiol/drospirenone [Yasmin; Berlex Canada] has been launched in Canada,","year":2005,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Drospirenone; Medicine; Launched; Ethinylestradiol; Gynecology; Environmental health; Population; Research methodology; Engineering","score_opus":0.030514620886917497,"score_gpt":0.2804845569241142,"score_spread":0.24996993603719672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241365950","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1839812,0.11279161,0.0042912485,0.042493533,0.005231459,0.0017082233,0.022594826,0.0030056313,0.62390226],"genre_scores_gemma":[0.2953762,0.029652104,0.0038215714,0.00613008,0.00043745205,0.00013329617,0.0079860445,0.00016401245,0.6562993],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99957556,0.00003029185,0.000015500333,0.000047981513,0.00022013372,0.00011059997],"domain_scores_gemma":[0.9993549,0.000037848367,0.00005168234,0.000021420292,0.00027852374,0.0002556309],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005016407,0.00045233438,0.0004471398,0.0005932545,0.0018074138,0.0008802178,0.0005011105,0.0008858416,0.030932117],"category_scores_gemma":[0.00050439796,0.00018752045,0.00030839717,0.0005480455,0.00074385066,0.00018844027,0.00044629924,0.0010048557,0.0048713987],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005662964,0.0010540312,0.016377142,0.0014268579,0.00016064341,0.0020428856,0.00028600992,0.0009929793,0.06456023,0.011284574,0.30773404,0.58841765],"study_design_scores_gemma":[0.0006640388,0.0011509393,0.028787468,0.00011750696,0.00007007707,0.0007124762,0.00027648167,0.0002665787,0.014221287,0.0003252827,0.9533728,0.000035077635],"about_ca_topic_score_codex":0.6268881,"about_ca_topic_score_gemma":0.88426274,"teacher_disagreement_score":0.3731119,"about_ca_system_score_codex":0.0061180354,"about_ca_system_score_gemma":0.025981085,"threshold_uncertainty_score":0.75061846},"labels":[],"label_agreement":null},{"id":"W4241551250","doi":"10.2165/00128413-200816220-00084","title":"Frovatriptan [Frova; Teva Neuroscience Canada] has been launched in Canada for the treatment of migraines with or without aura in adults.","year":2008,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Aura; Medicine; Pharmacy; Launched; Family medicine; Psychiatry; Migraine; Engineering","score_opus":0.05994279408294232,"score_gpt":0.2833808924903209,"score_spread":0.22343809840737858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241551250","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4951727,0.19703732,0.0012810343,0.017366871,0.0016221607,0.0017865087,0.018175999,0.00029061595,0.2672668],"genre_scores_gemma":[0.81279093,0.102351636,0.003928713,0.007340733,0.001107443,0.00042050105,0.008265004,0.00006591138,0.06372908],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99968517,0.00008418866,0.000020255207,0.000029531588,0.00012015236,0.000060744158],"domain_scores_gemma":[0.9993124,0.0001607367,0.00012489092,0.000028733679,0.00016257683,0.00021072419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067133544,0.00025522217,0.00055552705,0.00038384538,0.0009275834,0.00060351146,0.00047100236,0.00051934965,0.013807319],"category_scores_gemma":[0.0010546774,0.00012176275,0.00033723112,0.0007487069,0.00034517422,0.0002274893,0.00033848002,0.00087692414,0.0009691446],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02242147,0.0024161737,0.06297757,0.005982163,0.0010834474,0.002937746,0.0006044347,0.00046054545,0.034893278,0.005025359,0.14532413,0.7158737],"study_design_scores_gemma":[0.010325731,0.016544066,0.28771606,0.0014624044,0.0011517735,0.005474906,0.00081302354,0.00039472213,0.010915261,0.0011146973,0.66399,0.00009739647],"about_ca_topic_score_codex":0.17295028,"about_ca_topic_score_gemma":0.4101877,"teacher_disagreement_score":0.82704973,"about_ca_system_score_codex":0.0019978874,"about_ca_system_score_gemma":0.005508078,"threshold_uncertainty_score":0.34388715},"labels":[],"label_agreement":null},{"id":"W4241767819","doi":"10.2165/00128413-200313980-00049","title":"Health Canada has approved a new formulation of methylphenidate ['Concerta'; Janssen-Ortho Inc.] for use in children with ADHD","year":2003,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Methylphenidate; Medicine; Pharmacy; Psychiatry; Family medicine; Pediatrics; Attention deficit hyperactivity disorder","score_opus":0.07703450529964993,"score_gpt":0.3326952086648549,"score_spread":0.25566070336520497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241767819","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19379014,0.10847992,0.011225177,0.09359025,0.013242563,0.0038640916,0.014851769,0.0033368927,0.5576192],"genre_scores_gemma":[0.502817,0.05689463,0.027004825,0.03407035,0.0024270492,0.0007555644,0.008050404,0.0003774759,0.36760277],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99956733,0.00006344045,0.000022331878,0.000037826638,0.00023892336,0.000070216476],"domain_scores_gemma":[0.99935895,0.000074009025,0.000070259244,0.000022050188,0.00025387685,0.0002207768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005294724,0.00027227294,0.00052105886,0.00044133727,0.0009884288,0.00061600795,0.0008836725,0.0018378594,0.025573496],"category_scores_gemma":[0.0008769609,0.00019047034,0.0006121566,0.00035235763,0.00046430223,0.0002759092,0.00034136826,0.0019636136,0.0035755036],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031029624,0.0015813196,0.006037201,0.0011842109,0.00015316907,0.0012566075,0.00020403105,0.00021087196,0.03509698,0.0025910032,0.35938984,0.5891919],"study_design_scores_gemma":[0.0032065138,0.0030078976,0.027904928,0.00045389603,0.0002645437,0.002289545,0.00017618966,0.00061552617,0.008638668,0.0003567308,0.953028,0.000057512738],"about_ca_topic_score_codex":0.165128,"about_ca_topic_score_gemma":0.49251962,"teacher_disagreement_score":0.834872,"about_ca_system_score_codex":0.0024428288,"about_ca_system_score_gemma":0.0069928,"threshold_uncertainty_score":0.32833368},"labels":[],"label_agreement":null},{"id":"W4242075173","doi":"10.2165/00128413-200816600-00068","title":"Idebenone launched in Canada.","year":2008,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Coenzyme Q10 studies and effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Launched; Medicine; Idebenone; Optometry; Internal medicine; Engineering","score_opus":0.009847695806205469,"score_gpt":0.21519171013862048,"score_spread":0.205344014332415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242075173","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11893777,0.17341492,0.0028069562,0.036666144,0.0152410995,0.0015226476,0.018510694,0.0011135499,0.63178635],"genre_scores_gemma":[0.24521129,0.061787456,0.0023560612,0.0068482435,0.0009116786,0.00022187027,0.0049663233,0.0001292971,0.6775677],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99977523,0.00002561398,0.000006686013,0.000027862427,0.00009099218,0.000073694326],"domain_scores_gemma":[0.9997284,0.000017916193,0.000016388394,0.000009581382,0.00011573207,0.00011192613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033687794,0.000513128,0.00036491503,0.00062135316,0.00086414284,0.0008509605,0.00040027057,0.0009791944,0.027150543],"category_scores_gemma":[0.00035811233,0.00017327032,0.00023909706,0.00041354154,0.0005327226,0.00020143547,0.0004234637,0.0013939502,0.0047866413],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010557782,0.0007995646,0.006076528,0.0014165547,0.00017701498,0.0029922116,0.00018270145,0.00047034046,0.07418489,0.01278838,0.28949124,0.60086286],"study_design_scores_gemma":[0.0010848911,0.0016689112,0.01163049,0.00025939266,0.000064456704,0.00095835957,0.00013556736,0.00014431277,0.018917143,0.00059565343,0.9645097,0.000031104875],"about_ca_topic_score_codex":0.22309537,"about_ca_topic_score_gemma":0.3870467,"teacher_disagreement_score":0.77690464,"about_ca_system_score_codex":0.0037144949,"about_ca_system_score_gemma":0.009755133,"threshold_uncertainty_score":0.44359362},"labels":[],"label_agreement":null},{"id":"W4242890853","doi":"10.2165/00128413-200716110-00060","title":"Product approvals in Canada","year":2007,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Product (mathematics); Mathematics; Geometry","score_opus":0.3321649356588049,"score_gpt":0.42406658912105033,"score_spread":0.09190165346224544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242890853","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04226076,0.025716433,0.0011621347,0.0395348,0.010242094,0.0010378546,0.034534574,0.0010109278,0.8445005],"genre_scores_gemma":[0.12024953,0.007748218,0.0008525056,0.009048986,0.00066157535,0.00018901606,0.009129057,0.00031882548,0.8518023],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99293715,0.0003547469,0.00026335174,0.00049330393,0.004722932,0.0012284819],"domain_scores_gemma":[0.9842003,0.0007403063,0.00037381647,0.00027523297,0.012328612,0.0020816878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031499881,0.0005499688,0.0007260086,0.0036562018,0.004259442,0.0053047147,0.0011771136,0.0027304655,0.056208953],"category_scores_gemma":[0.009649679,0.00050479715,0.0011162147,0.0030704236,0.0011965402,0.00065489067,0.0008476631,0.0027617062,0.010894186],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004202416,0.00010860241,0.007277981,0.0003659675,0.000045719727,0.00039180947,0.00023973844,0.00030542133,0.00087054365,0.008221804,0.9079683,0.07378393],"study_design_scores_gemma":[0.000066384644,0.000063642765,0.028831398,0.00013716299,0.000030281395,0.000078209705,0.00019211727,0.00031989283,0.00056295394,0.000277328,0.96940976,0.00003091412],"about_ca_topic_score_codex":0.952157,"about_ca_topic_score_gemma":0.9678574,"teacher_disagreement_score":0.056208953,"about_ca_system_score_codex":0.03610805,"about_ca_system_score_gemma":0.11426671,"threshold_uncertainty_score":0.26198345},"labels":[],"label_agreement":null},{"id":"W4243106559","doi":"10.2165/00128413-200213420-00051","title":"Recent product news from Canada","year":2002,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Human auditory perception and evaluation","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacy; Product (mathematics); Family medicine","score_opus":0.04848438165908087,"score_gpt":0.24438120378044342,"score_spread":0.19589682212136256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243106559","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016001832,0.009749589,0.00051965035,0.054407395,0.03871062,0.0002791353,0.0078033344,0.0015896433,0.88534045],"genre_scores_gemma":[0.0010328251,0.0009982024,0.000091135065,0.0034630862,0.00040409694,0.000014027477,0.0007555402,0.0000807114,0.99316037],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982224,0.000046336634,0.000028484134,0.00011478405,0.0012496355,0.00033841544],"domain_scores_gemma":[0.9965867,0.00014545427,0.00006442047,0.00009167196,0.0023945018,0.0007172912],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010144067,0.0012256788,0.0009403295,0.0019462549,0.0046430537,0.008870819,0.0010041565,0.004469481,0.33664232],"category_scores_gemma":[0.0025914626,0.0005417325,0.0008140327,0.0022175987,0.000811318,0.0016104754,0.0011182842,0.0035224291,0.17368595],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015272857,0.00000884982,0.000059723618,0.000024210116,9.4846655e-7,0.000015431373,0.000008560534,0.000009637561,0.000059990198,0.00023737788,0.990458,0.009101921],"study_design_scores_gemma":[0.000008137412,0.000009872983,0.00076005905,0.000029874538,0.0000032307264,0.0000125915885,0.00007574288,0.000028498382,0.00007941541,0.00008137207,0.9989046,0.000006664575],"about_ca_topic_score_codex":0.60923237,"about_ca_topic_score_gemma":0.82853144,"teacher_disagreement_score":0.39076763,"about_ca_system_score_codex":0.0080527,"about_ca_system_score_gemma":0.0268902,"threshold_uncertainty_score":0.94619924},"labels":[],"label_agreement":null},{"id":"W4243495076","doi":"10.1007/bf03294092","title":"Ranibizumab launched for wet AMD in Canada","year":2007,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Launched; Medicine; Ranibizumab; Pharmacy; Optometry; Family medicine; Internal medicine; Engineering","score_opus":0.023996872037995158,"score_gpt":0.29786394733083654,"score_spread":0.2738670752928414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243495076","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5362244,0.046573885,0.0032140939,0.04989092,0.0033237266,0.0012842307,0.010653391,0.0010040111,0.34783128],"genre_scores_gemma":[0.82054687,0.01070967,0.0031198277,0.0064284382,0.00036731048,0.00009441165,0.0032791502,0.00014226968,0.15531203],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994179,0.000035287314,0.000019103458,0.000040091603,0.0002419718,0.00024568668],"domain_scores_gemma":[0.9989723,0.000044799162,0.00004842055,0.0000140531365,0.0005906934,0.00032967262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005846978,0.00022401169,0.00024375311,0.0006871043,0.0012762686,0.0014244011,0.0004543441,0.00062313763,0.0072325035],"category_scores_gemma":[0.0009586493,0.00016715234,0.00031445926,0.00063104735,0.00043824464,0.00020985748,0.0003698508,0.0010367073,0.00085879833],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010558595,0.00083247654,0.07068723,0.001045782,0.00032857474,0.009205097,0.0010579791,0.0017019651,0.078437075,0.016370447,0.25987887,0.54989594],"study_design_scores_gemma":[0.0015726315,0.0014565925,0.18724127,0.00027436178,0.0002606566,0.0020117257,0.00079204247,0.0015204053,0.022556279,0.00060953625,0.78164494,0.00005950292],"about_ca_topic_score_codex":0.9066964,"about_ca_topic_score_gemma":0.9491626,"teacher_disagreement_score":0.09330362,"about_ca_system_score_codex":0.021082392,"about_ca_system_score_gemma":0.04940623,"threshold_uncertainty_score":0.18770617},"labels":[],"label_agreement":null},{"id":"W4243923408","doi":"10.2165/00128413-200113150-00052","title":"Market news from Canada","year":2001,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Legal case studies and regulations","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacy; Family medicine","score_opus":0.020230963541874824,"score_gpt":0.28726694644531486,"score_spread":0.26703598290344005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243923408","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028468105,0.015593983,0.00020473942,0.10364455,0.022729037,0.00010225433,0.009752302,0.00053406466,0.8445922],"genre_scores_gemma":[0.0044711763,0.0020446868,0.00006449746,0.0058745914,0.000665316,0.0000134016755,0.0010883237,0.00006946974,0.9857085],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99806124,0.000049794162,0.000037085985,0.00013342776,0.0012358476,0.00048252678],"domain_scores_gemma":[0.9971848,0.00020419789,0.00007535526,0.00011283687,0.0018632296,0.0005595318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010100612,0.0008728373,0.0007528544,0.0023084942,0.006336105,0.011946405,0.0010460479,0.005261838,0.19645621],"category_scores_gemma":[0.0032342658,0.00055373815,0.00064590067,0.0033203713,0.0010082321,0.001633372,0.0010769377,0.0039574048,0.059215907],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000130374165,0.000005345266,0.00010825197,0.000020343627,0.0000012468402,0.000023191025,0.000021215828,0.000013812646,0.000027484715,0.0011922189,0.9938869,0.0046868813],"study_design_scores_gemma":[0.0000055891837,0.0000033863728,0.0012292847,0.000033030276,0.000002409354,0.000009204431,0.00009893017,0.000024707906,0.000049360395,0.00014924766,0.99838936,0.0000055431924],"about_ca_topic_score_codex":0.83816797,"about_ca_topic_score_gemma":0.93746054,"teacher_disagreement_score":0.19645621,"about_ca_system_score_codex":0.020344596,"about_ca_system_score_gemma":0.038149692,"threshold_uncertainty_score":0.6572115},"labels":[],"label_agreement":null},{"id":"W4244309416","doi":"10.2165/00128413-200615400-00068","title":"Auxilium Pharmaceuticals has received marketing approval from Health Canada for its topical testosterone gel","year":2006,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Immunotoxicology and immune responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacy; Drug approval; Family medicine; Pharmacology; Marketing; Drug; Business","score_opus":0.03935785095437948,"score_gpt":0.28920820495207183,"score_spread":0.24985035399769234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244309416","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16377038,0.16210593,0.011805683,0.015937323,0.0066831657,0.001215893,0.005490137,0.0039383327,0.6290531],"genre_scores_gemma":[0.39402297,0.032761652,0.008336561,0.0031035596,0.0013979998,0.00017409283,0.0027160922,0.00032963906,0.55715746],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99944955,0.000095973395,0.000016773667,0.00003680361,0.00031907557,0.000081797494],"domain_scores_gemma":[0.9991373,0.00020268688,0.00008191462,0.000043683714,0.000277287,0.00025708575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088210695,0.00041580404,0.0005669498,0.0010657498,0.0009369699,0.0008740374,0.00047996792,0.0011259645,0.060310975],"category_scores_gemma":[0.0007788976,0.00015785145,0.00052345626,0.0005126853,0.00039839972,0.00021955631,0.0002862326,0.0012391283,0.013271734],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021336977,0.0010584511,0.0028089408,0.0012007654,0.00004713017,0.0011739978,0.00016079466,0.00014274681,0.14788885,0.0032411853,0.08930157,0.75084186],"study_design_scores_gemma":[0.0006237081,0.0055241957,0.026120624,0.00032210813,0.00015844175,0.0066801673,0.00026019468,0.00047329624,0.10191814,0.00046686767,0.857403,0.00004928207],"about_ca_topic_score_codex":0.011679582,"about_ca_topic_score_gemma":0.031113105,"teacher_disagreement_score":0.060310975,"about_ca_system_score_codex":0.0009264784,"about_ca_system_score_gemma":0.002173436,"threshold_uncertainty_score":0.20176029},"labels":[],"label_agreement":null},{"id":"W4244333022","doi":"10.2165/00128413-200514710-00050","title":"Berlex has announced the Canadian approval of ethinylestradiol/drospirenone","year":2005,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Ethinylestradiol; Drospirenone; Pharmacy; Family medicine; Gynecology; Environmental health; Research methodology","score_opus":0.03238519109358545,"score_gpt":0.27179847325357454,"score_spread":0.23941328215998908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244333022","genre_codex":"other","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.052973315,0.07105035,0.005291701,0.21035065,0.03527297,0.001310457,0.011073945,0.0031511192,0.60952556],"genre_scores_gemma":[0.15599334,0.011444135,0.006512517,0.03589882,0.0029986592,0.000119300144,0.004069817,0.00030517514,0.7826583],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99820507,0.00010845129,0.000046844925,0.00012480155,0.0012143275,0.00030049492],"domain_scores_gemma":[0.9974324,0.00032044647,0.00012084916,0.00009780132,0.0013043255,0.0007242125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015814888,0.00043688962,0.00051180256,0.00084960135,0.002336736,0.0013139547,0.0008627853,0.0032569992,0.038164586],"category_scores_gemma":[0.0022983404,0.00027962172,0.00065743306,0.00043584552,0.0010138346,0.00033402757,0.00044623815,0.003164094,0.0059191803],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002694085,0.00030030523,0.004445357,0.0004177454,0.000078790305,0.0015834998,0.00013849285,0.00023824674,0.024394138,0.0071372027,0.72215307,0.23641908],"study_design_scores_gemma":[0.00024122332,0.00029317522,0.004790457,0.00003913005,0.000027059034,0.00050258165,0.000051571045,0.00015251592,0.0046306,0.00020681208,0.9890426,0.000022396538],"about_ca_topic_score_codex":0.2983338,"about_ca_topic_score_gemma":0.64790386,"teacher_disagreement_score":0.70166624,"about_ca_system_score_codex":0.0069386116,"about_ca_system_score_gemma":0.014211519,"threshold_uncertainty_score":0.5931946},"labels":[],"label_agreement":null},{"id":"W4244553985","doi":"10.2165/00128413-200715720-00069","title":"Cangene Corporation's hepatitis B immune globulin [HepaGam] has been granted a Notice of Compliance with condition by Health Canada,","year":2007,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Notice; Medicine; Hepatitis B immune globulin; Compliance (psychology); Corporation; Pharmacy; Family medicine; Immunology; Chronic hepatitis; Law; Political science; Social psychology","score_opus":0.037273384110760886,"score_gpt":0.30001617534630176,"score_spread":0.2627427912355409,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244553985","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021503866,0.004593463,0.0010669472,0.042372484,0.00949533,0.0010290513,0.0061054984,0.0018298214,0.91200346],"genre_scores_gemma":[0.021630589,0.00067675184,0.00091598276,0.0057639694,0.0003672365,0.00008176473,0.0018432857,0.0001538216,0.9685666],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99751174,0.00030129682,0.00008926529,0.00012805992,0.0015945579,0.0003751298],"domain_scores_gemma":[0.99489427,0.0010554561,0.00016630146,0.000514906,0.0024412002,0.000927932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027991282,0.00030830278,0.00042717755,0.0010071103,0.0031585505,0.0023702504,0.00076019124,0.0029804674,0.11496356],"category_scores_gemma":[0.008279319,0.00036451707,0.0003678991,0.00068699586,0.0010597318,0.00037152958,0.00063123775,0.0021375145,0.040842187],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046266816,0.00036039337,0.0030191224,0.00008008492,0.000016015334,0.00014848345,0.000102052836,0.000041027964,0.00258338,0.004363516,0.9315078,0.05731555],"study_design_scores_gemma":[0.00015231583,0.00027460523,0.0100528505,0.000045722903,0.000017258237,0.0001825487,0.00009202676,0.000087180895,0.002589063,0.0002183972,0.9862757,0.000012367792],"about_ca_topic_score_codex":0.14352198,"about_ca_topic_score_gemma":0.40149218,"teacher_disagreement_score":0.85647804,"about_ca_system_score_codex":0.0034205413,"about_ca_system_score_gemma":0.019175302,"threshold_uncertainty_score":0.3845914},"labels":[],"label_agreement":null},{"id":"W4245051009","doi":"10.2165/00128413-200514740-00048","title":"Health Canada has approved bortezomib [Velcade; Millennium Pharmaceuticals].","year":2005,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Healthcare Systems and Practices","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Bortezomib; Pharmacy; Pharmacology; Family medicine; Oncology; Internal medicine; Multiple myeloma","score_opus":0.22462814122089433,"score_gpt":0.51268809366099,"score_spread":0.28805995244009563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245051009","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03330292,0.06575408,0.003852539,0.1133072,0.006734433,0.00089591,0.009918763,0.0029540088,0.7632802],"genre_scores_gemma":[0.20316067,0.03950015,0.009336101,0.040142458,0.0009547689,0.00018884189,0.009532009,0.00043211668,0.6967529],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99899095,0.000083205574,0.00002797588,0.000063066334,0.0006248821,0.00020995484],"domain_scores_gemma":[0.998522,0.00013325317,0.000080749625,0.000036698548,0.000687696,0.00053970976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005963845,0.00041377064,0.00062524684,0.0007116595,0.0018722098,0.0014010939,0.0010375531,0.0017479197,0.052194092],"category_scores_gemma":[0.0017808371,0.00021663203,0.00061193726,0.00077233504,0.0006926133,0.00031848802,0.0005072257,0.0022304729,0.010086334],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007841016,0.00040068032,0.0042896997,0.0005191188,0.000056641256,0.00061234203,0.00009500963,0.00018774933,0.0060333195,0.003505711,0.7164144,0.2671013],"study_design_scores_gemma":[0.00026928695,0.00021016497,0.0043759807,0.00015277453,0.000048635313,0.0005299872,0.00009951188,0.00021299507,0.0028653203,0.0003552302,0.99085754,0.000022654565],"about_ca_topic_score_codex":0.48064077,"about_ca_topic_score_gemma":0.7510665,"teacher_disagreement_score":0.51935923,"about_ca_system_score_codex":0.006963014,"about_ca_system_score_gemma":0.030184004,"threshold_uncertainty_score":0.9556863},"labels":[],"label_agreement":null},{"id":"W4245109221","doi":"10.2165/00128413-200615390-00057","title":"Tequin: labelling updated in Canada","year":2006,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Horticultural and Viticultural Research","field":"Agricultural and Biological Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Labelling; Medicine; Biology; Biochemistry","score_opus":0.023633767765516515,"score_gpt":0.24201085054908436,"score_spread":0.21837708278356785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245109221","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0052135256,0.019005934,0.01086013,0.01618978,0.01834179,0.00080844556,0.20562267,0.007893065,0.71606463],"genre_scores_gemma":[0.011665368,0.013449568,0.011253617,0.0038284797,0.00041139685,0.00024205922,0.06405883,0.0024600115,0.89263064],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99784636,0.00015145529,0.00011617486,0.0002195336,0.0012127445,0.00045376067],"domain_scores_gemma":[0.9926644,0.00021160745,0.00020328249,0.00036472065,0.0060464097,0.0005094672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016765872,0.0011592447,0.0011535848,0.005090295,0.0052545057,0.005029838,0.0022489212,0.0024972276,0.1222726],"category_scores_gemma":[0.0045981547,0.0007856876,0.0008496337,0.009423502,0.0015206734,0.0018600136,0.0014713998,0.0033497105,0.0615629],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016765263,0.000021248943,0.0004393578,0.00035492537,0.0000073063525,0.000101550206,0.00016238359,0.00014694694,0.0021734908,0.0038487692,0.9382926,0.054283712],"study_design_scores_gemma":[0.0000056207814,0.000005897994,0.00064714643,0.000061929255,0.0000047228878,0.00003172211,0.00006253961,0.00003531986,0.0006073615,0.00027989526,0.99824214,0.000015622949],"about_ca_topic_score_codex":0.9315949,"about_ca_topic_score_gemma":0.9585712,"teacher_disagreement_score":0.1222726,"about_ca_system_score_codex":0.02669349,"about_ca_system_score_gemma":0.056742396,"threshold_uncertainty_score":0.40904266},"labels":[],"label_agreement":null},{"id":"W4245182772","doi":"10.2165/00128413-200615530-00070","title":"Product approvals in Canada","year":2006,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Product (mathematics); Pharmacy; Family medicine; Mathematics","score_opus":0.25689135826693954,"score_gpt":0.3872280217158144,"score_spread":0.13033666344887485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245182772","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04481821,0.024956947,0.0011699504,0.03860853,0.009847208,0.0010381795,0.03407288,0.0010107287,0.8444774],"genre_scores_gemma":[0.12234843,0.007323367,0.00084732333,0.008499047,0.0006291334,0.00018179155,0.008835242,0.0003076274,0.85102814],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9932255,0.00034082378,0.00025348313,0.00047361947,0.0045175394,0.0011890576],"domain_scores_gemma":[0.9847344,0.0007201945,0.00036242537,0.00026712616,0.011910667,0.0020051138],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030507226,0.0005357228,0.0007095717,0.0036308581,0.004213875,0.005161868,0.0011634966,0.0026784178,0.0558062],"category_scores_gemma":[0.009330807,0.0004949216,0.001090271,0.0030336527,0.0011627593,0.0006472943,0.00082111865,0.0026712345,0.010633436],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044021578,0.000113062255,0.007797898,0.00037163336,0.000045777055,0.00040882282,0.00025667742,0.00031844483,0.0009254559,0.008419062,0.9034267,0.07747624],"study_design_scores_gemma":[0.000066139655,0.00006560792,0.030336132,0.00013201119,0.00003053066,0.00007863481,0.00019815903,0.0003333244,0.00059236365,0.0002779916,0.96785796,0.00003118465],"about_ca_topic_score_codex":0.9526969,"about_ca_topic_score_gemma":0.9684248,"teacher_disagreement_score":0.0558062,"about_ca_system_score_codex":0.035477307,"about_ca_system_score_gemma":0.1114239,"threshold_uncertainty_score":0.25740713},"labels":[],"label_agreement":null},{"id":"W4245431836","doi":"10.2165/00128413-200715820-00064","title":"Zelnorm withdrawn from the US, Canadian market","year":2007,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Agricultural safety and regulations","field":"Agricultural and Biological Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacy; Family medicine","score_opus":0.010008326148351407,"score_gpt":0.19597577252054346,"score_spread":0.18596744637219206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245431836","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017867506,0.00418081,0.0010032695,0.02724295,0.0036035627,0.00062322523,0.016789244,0.0012037121,0.92748564],"genre_scores_gemma":[0.028141322,0.0009289344,0.0003577828,0.0064657526,0.000213983,0.00006601977,0.002804541,0.00012071468,0.96090096],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954442,0.00009936068,0.000109665845,0.0003019749,0.003129082,0.0009157312],"domain_scores_gemma":[0.99406487,0.00034809284,0.00009865875,0.00026847346,0.0045941183,0.0006257472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018937232,0.00057178445,0.0006834894,0.0023095796,0.0057164025,0.0055612763,0.0017819004,0.004853947,0.0910419],"category_scores_gemma":[0.005723589,0.00051372556,0.00093282125,0.0017750274,0.0014317163,0.00097217655,0.0011440782,0.0043553794,0.02282928],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035944514,0.00008680524,0.0020184747,0.00022321308,0.000029200468,0.0004727693,0.00027098288,0.00021191493,0.003829674,0.038087122,0.9007048,0.053705536],"study_design_scores_gemma":[0.00005835864,0.00003533957,0.0059660245,0.00007585669,0.000016795639,0.000072679286,0.00013895084,0.00012993939,0.0010629935,0.00048895855,0.99193525,0.000018824794],"about_ca_topic_score_codex":0.8560384,"about_ca_topic_score_gemma":0.9145762,"teacher_disagreement_score":0.14396161,"about_ca_system_score_codex":0.025204908,"about_ca_system_score_gemma":0.07745634,"threshold_uncertainty_score":0.3045655},"labels":[],"label_agreement":null},{"id":"W4246402844","doi":"10.2165/00128413-200012350-00055","title":"Canadian market news","year":2000,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Legal case studies and regulations","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacy; Advertising; Family medicine; Business","score_opus":0.014479951548192791,"score_gpt":0.2920210984169048,"score_spread":0.277541146868712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246402844","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009036673,0.0052365107,0.00013170451,0.027304856,0.0067486875,0.000073100055,0.0053324285,0.0003132775,0.95395577],"genre_scores_gemma":[0.0027374348,0.0017036613,0.00010040674,0.0019267766,0.00038282308,0.000011895445,0.0010548463,0.000058555677,0.9920236],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99728966,0.000061737606,0.000044692875,0.000151265,0.0019315989,0.0005211011],"domain_scores_gemma":[0.99696964,0.00015119699,0.000070147966,0.00013599952,0.0021666647,0.00050630915],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010104895,0.001035619,0.0007104205,0.004578104,0.0069661997,0.011883122,0.0015062641,0.0039339233,0.33364794],"category_scores_gemma":[0.004211255,0.00060183933,0.0007403148,0.005645111,0.0011604246,0.0021485833,0.0012456053,0.003105843,0.105370134],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000083902,0.000006198646,0.00008431208,0.000024551591,0.0000012750269,0.000022109976,0.000026012443,0.000015660522,0.00002696043,0.0040968973,0.98764193,0.008045707],"study_design_scores_gemma":[0.0000027806434,0.000001623052,0.00059408706,0.000023399838,0.0000016611691,0.0000071901472,0.00006582191,0.000023278932,0.00003057499,0.00026372817,0.9989814,0.000004332574],"about_ca_topic_score_codex":0.8887787,"about_ca_topic_score_gemma":0.95520973,"teacher_disagreement_score":0.33364794,"about_ca_system_score_codex":0.029386217,"about_ca_system_score_gemma":0.048609983,"threshold_uncertainty_score":0.9504703},"labels":[],"label_agreement":null},{"id":"W4246404833","doi":"10.2165/00128413-200113070-00051","title":"Canadian market news","year":2001,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Legal case studies and regulations","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Family medicine","score_opus":0.022353605644887777,"score_gpt":0.30974312144010446,"score_spread":0.2873895157952167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246404833","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008925177,0.0054801726,0.00013515814,0.02831651,0.0069269664,0.000076378405,0.0055928207,0.000314536,0.9522651],"genre_scores_gemma":[0.0026562025,0.0017052004,0.000097749515,0.0018650298,0.00037227545,0.00001230287,0.0010690617,0.000057605204,0.9921645],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99723864,0.0000659035,0.00004745584,0.00015914229,0.0019526574,0.00053628784],"domain_scores_gemma":[0.99688953,0.00015471563,0.00007071553,0.00014322728,0.002253303,0.0004885415],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001019837,0.001041639,0.00073271635,0.0045184065,0.007337691,0.012228626,0.0015036752,0.0040972587,0.34018487],"category_scores_gemma":[0.004263185,0.00063124916,0.00076101976,0.0056952126,0.0011511117,0.0021828723,0.0012490108,0.003202698,0.10767637],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008369918,0.000005995441,0.00008086046,0.000025115709,0.0000012681755,0.000021930578,0.000025899402,0.000015681031,0.000025376212,0.004113223,0.98793143,0.007744791],"study_design_scores_gemma":[0.0000027659885,0.000001582021,0.00057877094,0.000023642162,0.0000016476763,0.000007120626,0.000065641616,0.00002240035,0.000029266987,0.00025664072,0.9990062,0.000004335269],"about_ca_topic_score_codex":0.88722813,"about_ca_topic_score_gemma":0.9539694,"teacher_disagreement_score":0.34018487,"about_ca_system_score_codex":0.029688733,"about_ca_system_score_gemma":0.048796523,"threshold_uncertainty_score":0.9411462},"labels":[],"label_agreement":null},{"id":"W4246656322","doi":"10.2165/00128413-200816340-00067","title":"Tacrolimus ER launched in Canada for renal transplant.","year":2008,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Organ Donation and Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Launched; Tacrolimus; Renal transplant; Pharmacy; Family medicine; Internal medicine; Transplantation; Engineering","score_opus":0.023990365395594605,"score_gpt":0.2569539376459265,"score_spread":0.2329635722503319,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246656322","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06349606,0.08123211,0.0019276224,0.19412969,0.03134355,0.000342101,0.0075945053,0.0010108649,0.6189235],"genre_scores_gemma":[0.14501327,0.026670115,0.001901778,0.038518086,0.002115107,0.0000419058,0.002888185,0.00023299782,0.78261846],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99919885,0.000046849367,0.000022069838,0.000047014877,0.00043710181,0.0002481127],"domain_scores_gemma":[0.99841213,0.000099574565,0.000061856204,0.000027013057,0.00068764656,0.00071172166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005899264,0.00025740985,0.0002596405,0.00052035385,0.0018498895,0.0022018012,0.00039138828,0.0014672874,0.028475754],"category_scores_gemma":[0.0015372977,0.0001487176,0.00032501787,0.0005753845,0.00069226086,0.0003534145,0.00059788954,0.0028264055,0.0034759522],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000570765,0.00015244077,0.0094278855,0.00029942105,0.000050961346,0.0013083961,0.00014674662,0.00015596802,0.0028611203,0.011532514,0.824785,0.14870872],"study_design_scores_gemma":[0.000061219216,0.00006215648,0.0110108415,0.00013962461,0.000025011097,0.00046866373,0.000112353744,0.00012287284,0.0013398147,0.00027538472,0.98636717,0.000014793197],"about_ca_topic_score_codex":0.6709882,"about_ca_topic_score_gemma":0.8778803,"teacher_disagreement_score":0.3290118,"about_ca_system_score_codex":0.010431078,"about_ca_system_score_gemma":0.04092862,"threshold_uncertainty_score":0.66189885},"labels":[],"label_agreement":null},{"id":"W4246947765","doi":"10.2165/00128413-200816260-00082","title":"Extended-release bupropion approved for SAD in Canada.","year":2008,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Poisoning and overdose treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bupropion; Medicine; Pharmacology; Psychiatry; Smoking cessation","score_opus":0.026465223979017967,"score_gpt":0.27019203197768576,"score_spread":0.2437268079986678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246947765","genre_codex":"other","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3502052,0.06679261,0.0046765367,0.062362596,0.0030266454,0.0021007801,0.021683319,0.000927011,0.4882253],"genre_scores_gemma":[0.7315005,0.030598048,0.0049686623,0.012430166,0.00032163187,0.00027028774,0.008347836,0.000115874194,0.21144703],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999824,0.000022453885,0.0000098356795,0.000016925047,0.00006783623,0.000058987862],"domain_scores_gemma":[0.9995689,0.000025386105,0.000046597623,0.000009130051,0.00022365066,0.00012637768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017262834,0.00013384012,0.00019030279,0.00021928246,0.0007524506,0.00037853126,0.00034343585,0.00045156924,0.01973246],"category_scores_gemma":[0.00050370465,0.00009678167,0.00022694988,0.00029462462,0.00026774895,0.00015101011,0.00018781927,0.0008591441,0.0015733645],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054106074,0.0007188304,0.028603217,0.0012819604,0.00018968483,0.002746045,0.00040397575,0.00044452318,0.026659826,0.006132191,0.35922164,0.5681875],"study_design_scores_gemma":[0.0024272671,0.0019815974,0.14316632,0.0011141746,0.00019846148,0.0054855016,0.0007880755,0.0008394506,0.0072960975,0.0008509442,0.83578336,0.00006863043],"about_ca_topic_score_codex":0.5717067,"about_ca_topic_score_gemma":0.8904184,"teacher_disagreement_score":0.4282933,"about_ca_system_score_codex":0.0055807694,"about_ca_system_score_gemma":0.014584174,"threshold_uncertainty_score":0.86163116},"labels":[],"label_agreement":null},{"id":"W4247561095","doi":"10.2165/00128413-200313820-00041","title":"A new 20mg formulation of doxycycline hyclate ['Periostat'; CollaGenex Pharmaceuticals] has been approved in Canada","year":2003,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Doxycycline; Pharmacy; Pharmacology; Family medicine; Antibiotics; Microbiology","score_opus":0.05076536241035398,"score_gpt":0.3241503845011009,"score_spread":0.2733850220907469,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247561095","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5947311,0.10433365,0.032934185,0.004881852,0.0028308916,0.004958583,0.012394573,0.0059119756,0.2370232],"genre_scores_gemma":[0.75941867,0.02512412,0.024659729,0.0011745632,0.00031978445,0.00088568055,0.010642743,0.00024082171,0.17753391],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997974,0.000026736307,0.0000096574995,0.0000358265,0.000089462235,0.000040852843],"domain_scores_gemma":[0.9998379,0.000020035464,0.000025952162,0.0000138786645,0.00003234718,0.00006986698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003443338,0.0003897452,0.0004749165,0.0004618336,0.00038138768,0.00042888906,0.00055337645,0.0005456663,0.018216882],"category_scores_gemma":[0.00018635968,0.00017945815,0.00023311186,0.00022529408,0.00035410232,0.0002378792,0.00023686593,0.0009167984,0.004281594],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035675347,0.001265646,0.0006515218,0.00064454443,0.000043117223,0.00029879546,0.00008445783,0.000272424,0.6155953,0.0013200194,0.02758922,0.3486674],"study_design_scores_gemma":[0.0036283426,0.009318191,0.016049298,0.00018677917,0.00016239715,0.002096476,0.000083209045,0.0013838437,0.3454749,0.00021094839,0.6213508,0.0000548213],"about_ca_topic_score_codex":0.010165492,"about_ca_topic_score_gemma":0.031293705,"teacher_disagreement_score":0.9898345,"about_ca_system_score_codex":0.00087944657,"about_ca_system_score_gemma":0.0014262063,"threshold_uncertainty_score":0.060941517},"labels":[],"label_agreement":null},{"id":"W4247698475","doi":"10.2165/00128413-200615670-00056","title":"Health Canada updates information about Tamiflu","year":2006,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacy; Health information; Medical emergency; Environmental health; Family medicine; Health care; Economic growth","score_opus":0.12867541220596318,"score_gpt":0.37661253920261634,"score_spread":0.24793712699665316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247698475","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0054174922,0.012746581,0.0005978243,0.063467614,0.010537196,0.0007532469,0.30654335,0.0044768155,0.5954599],"genre_scores_gemma":[0.010846848,0.006232044,0.0012044848,0.017115077,0.0013681606,0.00030545538,0.04578423,0.00052477076,0.91661894],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986921,0.0000872433,0.00007353913,0.000064115055,0.00079662725,0.0002864436],"domain_scores_gemma":[0.9912492,0.0015061008,0.00041804207,0.0002532351,0.0051150853,0.0014583205],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013949203,0.00082953554,0.0011032778,0.0061845933,0.001941039,0.0027901877,0.001538591,0.002534165,0.29894987],"category_scores_gemma":[0.0067296345,0.00044691568,0.0007340127,0.0061316607,0.000462606,0.0007695206,0.0008714063,0.001461437,0.06988432],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042678155,0.000015192453,0.00031171393,0.00008017311,0.0000031485724,0.00002024078,0.000007819227,0.0000264625,0.000026610063,0.00012220742,0.98625344,0.01309034],"study_design_scores_gemma":[0.000072381525,0.000025951604,0.005154192,0.00015182218,0.000017708411,0.000028283312,0.00006530712,0.00017755518,0.00013347999,0.00012593092,0.99403113,0.00001622525],"about_ca_topic_score_codex":0.8108612,"about_ca_topic_score_gemma":0.8989624,"teacher_disagreement_score":0.8108612,"about_ca_system_score_codex":0.013314552,"about_ca_system_score_gemma":0.042075474,"threshold_uncertainty_score":0.9999629},"labels":[],"label_agreement":null},{"id":"W4247747570","doi":"10.2165/00128413-200514910-00054","title":"Omalizumab [Xolair; Novartis] has been launched in Canada for the treatment of moderate-to-severe, persistent asthma","year":2005,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Omalizumab; Medicine; Asthma; Mepolizumab; Launched; Pharmacy; Family medicine; Internal medicine; Immunology; Immunoglobulin E","score_opus":0.03356341046701216,"score_gpt":0.27641877988716185,"score_spread":0.24285536942014968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247747570","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.26389286,0.24283181,0.0062611364,0.06374234,0.0106753595,0.0015723204,0.009314443,0.0032447334,0.398465],"genre_scores_gemma":[0.6969832,0.05386128,0.011391623,0.022032836,0.002321816,0.00017522588,0.0085308775,0.00025313097,0.20445003],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995622,0.000051195093,0.00002311874,0.00004221753,0.00016846813,0.00015275551],"domain_scores_gemma":[0.9991516,0.00008339445,0.00008392462,0.000026713125,0.00027788212,0.00037642472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006119711,0.00037198336,0.0007749733,0.0004428717,0.0013656028,0.0010195121,0.00065328984,0.00090506265,0.01335655],"category_scores_gemma":[0.0007861014,0.00014225296,0.000498073,0.0004208993,0.00054676353,0.00022575575,0.00041479725,0.0017786075,0.0032514343],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008774928,0.0012547413,0.016654413,0.0013045963,0.00028168442,0.0026706248,0.00011265704,0.0005090987,0.042589903,0.0037377223,0.24929321,0.67281646],"study_design_scores_gemma":[0.0046145497,0.0041195652,0.097756445,0.0004552141,0.0005308807,0.0052285907,0.0001561525,0.0014919911,0.021489594,0.0007666084,0.86329746,0.00009298742],"about_ca_topic_score_codex":0.18119173,"about_ca_topic_score_gemma":0.42728832,"teacher_disagreement_score":0.81880826,"about_ca_system_score_codex":0.003734437,"about_ca_system_score_gemma":0.00785938,"threshold_uncertainty_score":0.3602742},"labels":[],"label_agreement":null},{"id":"W4247784427","doi":"10.2165/00128413-200414660-00007","title":"Additional pertussis booster warranted among Canadian teens","year":2004,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Bacterial Infections and Vaccines","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Booster (rocketry); Family medicine; Pediatrics","score_opus":0.01120816360198514,"score_gpt":0.22021411404630223,"score_spread":0.20900595044431708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247784427","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96767455,0.0020427715,0.00011427779,0.0066788546,0.0002873648,0.0001367957,0.0012957099,0.000056978184,0.021712786],"genre_scores_gemma":[0.99299896,0.0010089406,0.0003139716,0.001289855,0.00004218285,0.000028097611,0.00033422522,0.000010248047,0.003973427],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991334,0.00005050301,0.000023096662,0.00006055439,0.00023867322,0.00049376814],"domain_scores_gemma":[0.99844897,0.000077782555,0.00018979672,0.000017835833,0.00038784218,0.0008775978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045154904,0.00020007582,0.00033410208,0.0007759819,0.0038194908,0.0008906666,0.0007811777,0.00097533735,0.012058834],"category_scores_gemma":[0.002256185,0.00021946926,0.00047734394,0.0009631935,0.00029065923,0.00033999005,0.00041428691,0.0013043532,0.0004315984],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006302444,0.0008097473,0.8927952,0.00015539098,0.00004282762,0.0021543063,0.002049805,0.0001469297,0.000922038,0.00062023994,0.026953572,0.07271975],"study_design_scores_gemma":[0.000093973955,0.000594506,0.9648945,0.00042398117,0.00015168254,0.0016626721,0.010121626,0.00053494086,0.0006062021,0.00014355248,0.020738523,0.00003388958],"about_ca_topic_score_codex":0.9423127,"about_ca_topic_score_gemma":0.97881067,"teacher_disagreement_score":0.057687283,"about_ca_system_score_codex":0.015916247,"about_ca_system_score_gemma":0.03305213,"threshold_uncertainty_score":0.116054},"labels":[],"label_agreement":null},{"id":"W4248294968","doi":"10.2165/00128413-200816330-00064","title":"Zotarolimus-eluting stent approved for CAD in Canada.","year":2008,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Coronary Interventions and Diagnostics","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Zotarolimus; CAD; Pharmacy; Medical physics; Stent; Internal medicine; Drug-eluting stent; Family medicine; Engineering; Engineering drawing","score_opus":0.04155910093374337,"score_gpt":0.2865467605291062,"score_spread":0.24498765959536284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248294968","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3450106,0.10171314,0.0021326062,0.16094223,0.0049273297,0.0007164978,0.043995045,0.0006664147,0.3398961],"genre_scores_gemma":[0.6902981,0.06150966,0.0040973956,0.028393863,0.0010188647,0.00014882321,0.022483071,0.0001447819,0.19190551],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997023,0.000021572538,0.000014489665,0.000020340109,0.00013275981,0.000108482796],"domain_scores_gemma":[0.9992042,0.000048798243,0.000052307707,0.000009953555,0.00042813586,0.0002566304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022835445,0.00015225731,0.0002297458,0.00060376234,0.00091406394,0.0007670142,0.00044035667,0.0007550087,0.011731541],"category_scores_gemma":[0.0010425161,0.0001176511,0.00024159254,0.0009879749,0.00028764334,0.00022267523,0.00018079867,0.0011701477,0.00094947533],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024549637,0.00038682966,0.074158505,0.0007947735,0.0002151888,0.0023671142,0.00030765182,0.0004801857,0.0061762324,0.0073046023,0.66663796,0.23871599],"study_design_scores_gemma":[0.0010369293,0.0003869382,0.24971911,0.0005150089,0.00034917606,0.0024025014,0.0005369939,0.0015681013,0.003374303,0.0009226211,0.7391216,0.00006671194],"about_ca_topic_score_codex":0.9004639,"about_ca_topic_score_gemma":0.9718383,"teacher_disagreement_score":0.09953612,"about_ca_system_score_codex":0.010369547,"about_ca_system_score_gemma":0.038269006,"threshold_uncertainty_score":0.20024455},"labels":[],"label_agreement":null},{"id":"W4248304185","doi":"10.2165/00128413-200615450-00013","title":"Immunising healthy infants against influenza not worth it in Canada?","year":2006,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacy; Environmental health; Family medicine","score_opus":0.0779504830436148,"score_gpt":0.3805162292940481,"score_spread":0.3025657462504333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248304185","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8055389,0.04965188,0.00013437384,0.111212656,0.00081743597,0.00034716932,0.0036782427,0.000023382117,0.028595999],"genre_scores_gemma":[0.9474265,0.02789539,0.00055963255,0.016113153,0.00019664952,0.00015415235,0.0007934973,0.000012029698,0.0068490137],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99758637,0.0005147261,0.00010386628,0.00012680993,0.00049743825,0.0011708611],"domain_scores_gemma":[0.9929293,0.0007233488,0.00070596643,0.00011394925,0.0024000509,0.003127526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026016296,0.00034250022,0.0005177776,0.0006469369,0.0043251812,0.0020462116,0.0014380232,0.0017671804,0.0030620014],"category_scores_gemma":[0.009227138,0.0003218895,0.00031790134,0.0026867164,0.0010491806,0.00089542835,0.0007864412,0.0021754464,0.0002357208],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004600008,0.0013776508,0.7305577,0.0020750717,0.00031302913,0.001179789,0.009764759,0.0004850459,0.0009625994,0.0074370727,0.07488747,0.16635978],"study_design_scores_gemma":[0.0006488516,0.001220484,0.9261541,0.0022420182,0.0005063059,0.00032071202,0.022593971,0.0003775763,0.00047263567,0.0007416538,0.04463747,0.000084267456],"about_ca_topic_score_codex":0.9964916,"about_ca_topic_score_gemma":0.99801755,"teacher_disagreement_score":0.060206685,"about_ca_system_score_codex":0.060206685,"about_ca_system_score_gemma":0.1726796,"threshold_uncertainty_score":0.43683207},"labels":[],"label_agreement":null},{"id":"W4248712378","doi":"10.2165/00128413-200515060-00051","title":"Safety updates to Canadian labelling for Duragesic","year":2005,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Labelling; Medicine; Pharmacy; Medical emergency; Family medicine; Criminology; Psychology","score_opus":0.02394607577086246,"score_gpt":0.3393357333737358,"score_spread":0.31538965760287335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248712378","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012312569,0.015379473,0.006911206,0.23007365,0.040780585,0.00077496003,0.008814961,0.0030406942,0.68191195],"genre_scores_gemma":[0.074029505,0.011107385,0.018091079,0.1708759,0.0057749897,0.00032595586,0.0068280455,0.00095721375,0.7120099],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98875415,0.0012526754,0.00058925967,0.00047387145,0.0076158517,0.0013141754],"domain_scores_gemma":[0.9583477,0.0044211075,0.0012445913,0.0012813282,0.03218897,0.0025163817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006984204,0.0006868718,0.00073230756,0.003414406,0.005547418,0.004243118,0.0035018292,0.010090463,0.040163063],"category_scores_gemma":[0.024197198,0.00063906744,0.0015752744,0.0024850802,0.0018346405,0.0011078392,0.0010593311,0.008022418,0.009749432],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015601628,0.00007489007,0.0009373653,0.00027697848,0.000013950023,0.0002548304,0.00028226126,0.00013706017,0.0013485285,0.007105141,0.93766195,0.051751044],"study_design_scores_gemma":[0.00001857142,0.00003915234,0.0019757065,0.00016128152,0.000022083697,0.0001553863,0.00011434741,0.00007568966,0.0006773729,0.0004280659,0.9963103,0.000021966365],"about_ca_topic_score_codex":0.6898334,"about_ca_topic_score_gemma":0.8148617,"teacher_disagreement_score":0.3101666,"about_ca_system_score_codex":0.020381259,"about_ca_system_score_gemma":0.06250339,"threshold_uncertainty_score":0.6239865},"labels":[],"label_agreement":null},{"id":"W4248803141","doi":"10.2165/00128413-200213480-00012","title":"Amiodarone lowers costs for atrial fibrillation in Canada","year":2002,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Amiodarone; Atrial fibrillation; Cardiology; Internal medicine; Dronedarone; Pharmacy; Family medicine","score_opus":0.06332727414332998,"score_gpt":0.3143081856551948,"score_spread":0.25098091151186486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248803141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8639143,0.008744954,0.00035572506,0.06685433,0.0005853926,0.00014389666,0.010488243,0.00012237698,0.048790734],"genre_scores_gemma":[0.9871783,0.0027722055,0.0003804392,0.0025531643,0.0001821408,0.00002770457,0.0013418333,0.000015699203,0.005548587],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99926597,0.00008323229,0.00003908724,0.000033791137,0.00030004873,0.0002778837],"domain_scores_gemma":[0.9969168,0.00026676682,0.00031862105,0.000028667144,0.0011033372,0.0013658389],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003283788,0.00016485341,0.00034101677,0.00085930625,0.0013790164,0.0009829876,0.0008031134,0.0007272707,0.00565986],"category_scores_gemma":[0.004788511,0.00021694374,0.00045277659,0.0015626969,0.00030089592,0.00036297084,0.00038307006,0.0009207263,0.00015724078],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015928163,0.00048977375,0.7326845,0.00045237824,0.00052324025,0.00109779,0.0004463008,0.0037875904,0.00076758966,0.0030149305,0.11211758,0.14302556],"study_design_scores_gemma":[0.0006523709,0.00017215595,0.97349155,0.00015485239,0.00034704863,0.00045922922,0.00058860605,0.003187932,0.0003128006,0.0005360773,0.020060647,0.000036749392],"about_ca_topic_score_codex":0.98720896,"about_ca_topic_score_gemma":0.9940593,"teacher_disagreement_score":0.031975456,"about_ca_system_score_codex":0.031975456,"about_ca_system_score_gemma":0.08070597,"threshold_uncertainty_score":0.23199928},"labels":[],"label_agreement":null},{"id":"W4248864116","doi":"10.2165/00128413-200816340-00055","title":"Health Canada issues foreign product alert","year":2008,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Global Public Health Policies and Epidemiology","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacy; Product (mathematics); Medical emergency; Family medicine","score_opus":0.051277173733828965,"score_gpt":0.3116325408963768,"score_spread":0.26035536716254787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248864116","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021730454,0.0042802086,0.0003572003,0.4419615,0.133664,0.00066008215,0.025367351,0.0019664282,0.38957006],"genre_scores_gemma":[0.003996767,0.0027899244,0.0002863986,0.111830525,0.016674386,0.00013545889,0.005188042,0.0001949492,0.85890347],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958269,0.00016134261,0.00021926592,0.00017184271,0.002879891,0.0007406742],"domain_scores_gemma":[0.9827372,0.0016997274,0.0005365641,0.0004659812,0.010825314,0.003735296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019389292,0.0012774318,0.0017692838,0.0043513305,0.004936198,0.0068313824,0.002477629,0.0251015,0.20240021],"category_scores_gemma":[0.011153076,0.0009324383,0.0018845784,0.003072132,0.0012674321,0.0014168054,0.0014821303,0.008328458,0.074219495],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007870992,0.000013680257,0.00021140029,0.000016331238,0.0000016635905,0.000037837446,0.000003168205,0.0000085025895,0.000008909821,0.000062629595,0.99655616,0.0030719647],"study_design_scores_gemma":[0.000032295102,0.000014545887,0.0035029508,0.000090433605,0.000012061805,0.000058508453,0.00007852963,0.00009246974,0.00006203467,0.0001753996,0.99586725,0.0000135433065],"about_ca_topic_score_codex":0.5940145,"about_ca_topic_score_gemma":0.7417433,"teacher_disagreement_score":0.40598547,"about_ca_system_score_codex":0.0140744755,"about_ca_system_score_gemma":0.049406487,"threshold_uncertainty_score":0.8167528},"labels":[],"label_agreement":null},{"id":"W4249028562","doi":"10.2165/00128413-200615330-00059","title":"Health Canada has received 29 domestic reports of suspected isotretinoin [Accutane]-associated vascular disorders","year":2006,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Isotretinoin; Dermatology; Acne","score_opus":0.007453704686786261,"score_gpt":0.24865689757772944,"score_spread":0.24120319289094316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249028562","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.45902827,0.019056987,0.0015723458,0.044967942,0.004824268,0.00055190845,0.00975613,0.0008278354,0.4594144],"genre_scores_gemma":[0.87434703,0.01097206,0.0029485563,0.024443017,0.0014697713,0.00004383129,0.0059640235,0.00024092801,0.079570726],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979589,0.00015388557,0.00019333964,0.00011311103,0.0010659744,0.00051481376],"domain_scores_gemma":[0.9881471,0.001766462,0.0012332621,0.00027095154,0.0066625914,0.0019196856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007247867,0.00057658507,0.00042743457,0.0048829094,0.003558327,0.0016677665,0.0011250793,0.0025736378,0.0164705],"category_scores_gemma":[0.004931722,0.00034761248,0.0004003635,0.0037166642,0.0012530276,0.00038816786,0.00098455,0.0012013962,0.002171061],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003868585,0.00048340368,0.6618386,0.00056887325,0.00017184227,0.096455045,0.0014013465,0.00019066973,0.0036746578,0.0016687411,0.16596231,0.06719768],"study_design_scores_gemma":[0.000101574624,0.0004080992,0.4853683,0.0005443082,0.00033113224,0.08136236,0.0072835935,0.00084427884,0.006859427,0.00034018062,0.41640535,0.00015133376],"about_ca_topic_score_codex":0.64720404,"about_ca_topic_score_gemma":0.7930617,"teacher_disagreement_score":0.35279596,"about_ca_system_score_codex":0.0069732456,"about_ca_system_score_gemma":0.015371959,"threshold_uncertainty_score":0.7097473},"labels":[],"label_agreement":null},{"id":"W4249598482","doi":"10.1007/bf03272663","title":"Atorvastatin calcium approved in Canada for MI prevention","year":2007,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Atorvastatin; Pharmacy; Pharmacology; Internal medicine; Family medicine","score_opus":0.01454379219708397,"score_gpt":0.2792005168786046,"score_spread":0.2646567246815206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249598482","genre_codex":"other","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19512986,0.12030836,0.0060915058,0.106124416,0.007959762,0.0014460096,0.02788775,0.0022255392,0.53282684],"genre_scores_gemma":[0.7335276,0.041195635,0.008895393,0.02161621,0.0014790505,0.000366559,0.0130132185,0.0002522772,0.17965409],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993112,0.00011461048,0.0000456337,0.000059490896,0.00023509837,0.00023394052],"domain_scores_gemma":[0.99857664,0.00010955749,0.00015192688,0.000034603934,0.00073639076,0.00039086322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044437763,0.00027377935,0.00051301945,0.0008536096,0.001157655,0.0010200659,0.0005835518,0.0009595933,0.015633445],"category_scores_gemma":[0.0017024811,0.00017430185,0.00061524316,0.0012855938,0.00049888645,0.00020776698,0.00031356115,0.0017252677,0.001970691],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012087061,0.0010510252,0.054259215,0.0016695231,0.00065378804,0.0026783769,0.00024088327,0.00059819996,0.02453396,0.016216924,0.410524,0.47548705],"study_design_scores_gemma":[0.005066925,0.0015744787,0.11024383,0.00079822174,0.0007370648,0.0018761343,0.00022636207,0.000714242,0.007067889,0.0010937015,0.87052757,0.0000737352],"about_ca_topic_score_codex":0.659989,"about_ca_topic_score_gemma":0.8476559,"teacher_disagreement_score":0.340011,"about_ca_system_score_codex":0.008069294,"about_ca_system_score_gemma":0.030451367,"threshold_uncertainty_score":0.6840268},"labels":[],"label_agreement":null},{"id":"W4249991781","doi":"10.2165/00128413-200414460-00045","title":"Product approvals in Canada","year":2004,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Product (mathematics); Pharmacy; Family medicine","score_opus":0.3188622538745315,"score_gpt":0.4054423090858969,"score_spread":0.08658005521136541,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249991781","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.045777306,0.025007382,0.0011797636,0.039559785,0.009775618,0.0010453999,0.03370635,0.0010210932,0.8429273],"genre_scores_gemma":[0.1215866,0.007238364,0.00083916663,0.008527531,0.0006312739,0.000181233,0.008801388,0.0003083842,0.851886],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9929107,0.00035463207,0.0002638626,0.00048942026,0.004742075,0.0012394201],"domain_scores_gemma":[0.98405576,0.0007559107,0.0003823841,0.00028019716,0.0124347955,0.0020908178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031571458,0.0005355607,0.0007155519,0.0037217583,0.0043121935,0.0052918275,0.0011683211,0.0027322385,0.055842284],"category_scores_gemma":[0.009703829,0.0005091252,0.0011074312,0.003093819,0.0011895235,0.0006628304,0.0008433633,0.0027151972,0.010650043],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044554708,0.000113731425,0.008164447,0.0003718887,0.000046388963,0.00041283094,0.00027114848,0.00032408893,0.00092894176,0.008677938,0.90190446,0.07833854],"study_design_scores_gemma":[0.00006455422,0.00006530644,0.030539686,0.00012963261,0.00003071888,0.00007853488,0.00020188678,0.00032630938,0.00058685546,0.00028072088,0.9676646,0.000031293584],"about_ca_topic_score_codex":0.95350194,"about_ca_topic_score_gemma":0.9685733,"teacher_disagreement_score":0.055842284,"about_ca_system_score_codex":0.03628573,"about_ca_system_score_gemma":0.11332116,"threshold_uncertainty_score":0.26327264},"labels":[],"label_agreement":null},{"id":"W4250118342","doi":"10.2165/00128413-200615470-00054","title":"Safety information on gadodiamide issued in Canada","year":2006,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Gadodiamide; Pharmacy; Physical therapy; Family medicine; Radiology; Magnetic resonance imaging","score_opus":0.015536238022708234,"score_gpt":0.3189604577555457,"score_spread":0.30342421973283745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250118342","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.080864765,0.011027091,0.0017696705,0.05659952,0.003941306,0.00058847,0.036006775,0.0009957929,0.80820674],"genre_scores_gemma":[0.27500358,0.014633326,0.00166762,0.02154763,0.0010162245,0.000080068734,0.016677368,0.00019991363,0.6691743],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99830234,0.00007954363,0.00009259114,0.000057905712,0.001243398,0.0002241686],"domain_scores_gemma":[0.9910108,0.0009108024,0.00054834253,0.00011757727,0.0067724804,0.0006399449],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077684683,0.00022835554,0.00025409705,0.0028024842,0.002472141,0.0017118411,0.00063909485,0.0013790801,0.032302357],"category_scores_gemma":[0.0054852753,0.0002453566,0.0003201203,0.0022206698,0.0005017316,0.00032707126,0.0003448639,0.0011204073,0.005251759],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004582655,0.00018769427,0.04103066,0.00048954034,0.00003202324,0.0016437403,0.0006873717,0.0005701752,0.0035644535,0.0041374117,0.7870753,0.16012344],"study_design_scores_gemma":[0.000064572305,0.00014942621,0.09477573,0.0003453508,0.000036366637,0.0005876441,0.00041285862,0.00052698137,0.0023517616,0.00047602283,0.90022993,0.0000433906],"about_ca_topic_score_codex":0.9242712,"about_ca_topic_score_gemma":0.93116814,"teacher_disagreement_score":0.075728774,"about_ca_system_score_codex":0.015031591,"about_ca_system_score_gemma":0.05090358,"threshold_uncertainty_score":0.15234947},"labels":[],"label_agreement":null},{"id":"W4250267269","doi":"10.2165/00128413-200112860-00058","title":"Recent approvals in the Canadian market","year":2001,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Biotechnology and Related Fields","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacy; Family medicine","score_opus":0.02371898196635164,"score_gpt":0.279133966060813,"score_spread":0.25541498409446134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250267269","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018198036,0.07294957,0.0017522324,0.09859438,0.014693627,0.00042108836,0.0064452696,0.00071282143,0.7862329],"genre_scores_gemma":[0.21734375,0.0811772,0.003552059,0.049384966,0.005934408,0.00021149687,0.0070825014,0.00039915033,0.6349144],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99518776,0.0002412539,0.00013251962,0.0003140602,0.003262399,0.0008619956],"domain_scores_gemma":[0.9869767,0.0009717253,0.0004093294,0.0002753306,0.009574145,0.0017926758],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031796198,0.0006478321,0.0006351229,0.0026249392,0.0030210628,0.00427662,0.0010459024,0.0032207035,0.070142455],"category_scores_gemma":[0.0112417145,0.00026519867,0.0010050314,0.0028770238,0.0018927879,0.0010561675,0.0006962002,0.0030710336,0.009172907],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005098706,0.000114148745,0.002998943,0.00077633245,0.000047009456,0.0006125628,0.00024866223,0.0001875312,0.0019202956,0.013083607,0.77340114,0.20609994],"study_design_scores_gemma":[0.000053284803,0.0000634789,0.006154294,0.00016948706,0.00003744948,0.00019501516,0.00013739598,0.00007528205,0.00060719246,0.0003576293,0.9921306,0.000018930265],"about_ca_topic_score_codex":0.6633904,"about_ca_topic_score_gemma":0.8194538,"teacher_disagreement_score":0.3366096,"about_ca_system_score_codex":0.02313244,"about_ca_system_score_gemma":0.042201396,"threshold_uncertainty_score":0.67718387},"labels":[],"label_agreement":null},{"id":"W4250351784","doi":"10.2165/00128413-200414390-00057","title":"A blueprint for the Canadian Medication Incident Reporting and Prevention System (CMIRPS) has been developed","year":2004,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Blueprint; Medicine; Pharmacy; Family medicine; Medical emergency; Engineering","score_opus":0.2836038758750553,"score_gpt":0.44070278801471624,"score_spread":0.15709891213966093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250351784","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013269319,0.004346046,0.26155883,0.42561457,0.034328185,0.010463004,0.015067298,0.041967623,0.19338508],"genre_scores_gemma":[0.052056547,0.004071366,0.5131516,0.13370305,0.005235241,0.0037090948,0.019195884,0.005282129,0.2635951],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.95778376,0.0059541725,0.0032581757,0.0020557248,0.026255349,0.0046928558],"domain_scores_gemma":[0.7924938,0.021419318,0.008193186,0.011538365,0.13026741,0.036087926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04821473,0.0013614187,0.0012241808,0.0069246623,0.0043980954,0.01055878,0.006130873,0.0087564485,0.022158457],"category_scores_gemma":[0.06969098,0.0014471676,0.0015930216,0.005029671,0.0034970187,0.0040868255,0.0033371402,0.00989883,0.0163741],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049073464,0.0003524252,0.0057377843,0.00028790577,0.000042041902,0.00025638685,0.00039375667,0.0015580694,0.0019026714,0.018672511,0.7861208,0.18462667],"study_design_scores_gemma":[0.00007196426,0.00016730468,0.024213968,0.00041964996,0.00003673679,0.00021197596,0.00040807136,0.002844295,0.001628928,0.0030959828,0.9667455,0.00015554692],"about_ca_topic_score_codex":0.5183845,"about_ca_topic_score_gemma":0.601657,"teacher_disagreement_score":0.9680316,"about_ca_system_score_codex":0.03196844,"about_ca_system_score_gemma":0.17175475,"threshold_uncertainty_score":0.96890366},"labels":[],"label_agreement":null},{"id":"W4252046852","doi":"10.2165/00128413-200715940-00063","title":"Health Canada has issued a Qualifying Notice for the approval of dronabinol/cannabidiol","year":2007,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cannabidiol; Dronabinol; Medicine; Notice; Pharmacy; Cannabis; Family medicine; Psychiatry; Law; Internal medicine; Cannabinoid; Political science","score_opus":0.05891339858623662,"score_gpt":0.37029963544527245,"score_spread":0.3113862368590358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252046852","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.026790773,0.010153501,0.004924391,0.1781645,0.031188164,0.0040406273,0.008510727,0.0027945985,0.73343277],"genre_scores_gemma":[0.04716375,0.002778792,0.003943773,0.060674958,0.0026250868,0.00022939635,0.0026997782,0.0003173512,0.8795671],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9938293,0.0004302279,0.00017154557,0.00028047574,0.004041118,0.0012472824],"domain_scores_gemma":[0.9847372,0.0025976833,0.00038423706,0.00047956427,0.00921153,0.0025897657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005187426,0.0006550805,0.0009938172,0.0021485025,0.0072431867,0.003872953,0.0022296177,0.012171339,0.051963665],"category_scores_gemma":[0.010830268,0.00077581673,0.001325444,0.00092322286,0.0024493947,0.00064373895,0.0008653991,0.0071992395,0.010619314],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045158705,0.00030500212,0.0021839093,0.00023590711,0.000045680757,0.0012168601,0.00015745702,0.000083492436,0.0060290466,0.006735234,0.9399725,0.042583264],"study_design_scores_gemma":[0.00022133219,0.00026196588,0.0070694946,0.000089922556,0.00006370975,0.0003869028,0.00014207742,0.00026059616,0.0036115383,0.00048975425,0.98735774,0.00004501519],"about_ca_topic_score_codex":0.48203167,"about_ca_topic_score_gemma":0.78929883,"teacher_disagreement_score":0.5179683,"about_ca_system_score_codex":0.011695887,"about_ca_system_score_gemma":0.07711437,"threshold_uncertainty_score":0.95845187},"labels":[],"label_agreement":null},{"id":"W4252155602","doi":"10.2165/00128413-200515050-00055","title":"Product approvals in Canada","year":2005,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacy; Product (mathematics); Family medicine","score_opus":0.3203988441390227,"score_gpt":0.41083534119179926,"score_spread":0.09043649705277657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252155602","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.043086052,0.02544693,0.0011772767,0.039686777,0.010009171,0.0010490377,0.033713162,0.0010038576,0.8448277],"genre_scores_gemma":[0.12069333,0.0076509896,0.00086496066,0.008932983,0.0006494239,0.00018765261,0.009018552,0.00031533887,0.8516868],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9928175,0.000358892,0.0002671032,0.00049584935,0.004818721,0.0012418723],"domain_scores_gemma":[0.9839585,0.0007484885,0.00037806956,0.0002786772,0.01256247,0.0020737823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031882792,0.00054410123,0.00072171167,0.003696934,0.004299745,0.005320706,0.0011775836,0.0027267532,0.055716336],"category_scores_gemma":[0.009811604,0.00050760363,0.0011155339,0.0030950767,0.0011948678,0.0006638422,0.0008429109,0.0027496794,0.010758081],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004257352,0.000109302244,0.007507274,0.0003673199,0.000045550223,0.00039286603,0.00025186897,0.00031040452,0.0008764471,0.008468549,0.9054479,0.07579681],"study_design_scores_gemma":[0.00006593237,0.0000640686,0.028898282,0.00013484071,0.00003050786,0.00007726026,0.00019667558,0.00032049278,0.0005688509,0.0002812402,0.9693309,0.00003106706],"about_ca_topic_score_codex":0.9537064,"about_ca_topic_score_gemma":0.9689951,"teacher_disagreement_score":0.963405,"about_ca_system_score_codex":0.036594987,"about_ca_system_score_gemma":0.11553426,"threshold_uncertainty_score":0.26551646},"labels":[],"label_agreement":null},{"id":"W4252472898","doi":"10.2165/00128413-200213410-00052","title":"Recent product approvals in Canada","year":2002,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacy; Product (mathematics); Family medicine","score_opus":0.44171867976148776,"score_gpt":0.3969668101560449,"score_spread":0.04475186960544286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252472898","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.036478303,0.07263007,0.0024664113,0.0598929,0.02326053,0.0009838919,0.042615827,0.0016239489,0.76004815],"genre_scores_gemma":[0.12911715,0.027239954,0.0017476347,0.01472346,0.0021218923,0.0002229854,0.016204828,0.00047995395,0.8081421],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948896,0.00020964537,0.00018259941,0.00030202378,0.0037667383,0.0006492891],"domain_scores_gemma":[0.9831402,0.00074509496,0.0004993911,0.00027177614,0.014012022,0.0013315254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028588371,0.0005992431,0.0007453351,0.003602497,0.002792128,0.0048732273,0.0010346067,0.002666196,0.04819506],"category_scores_gemma":[0.009293293,0.00040902532,0.0010849036,0.0033685504,0.001309774,0.0007748392,0.0005836046,0.0027373794,0.010237981],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005267345,0.00008950393,0.0045691365,0.0005319531,0.000045193487,0.0002664137,0.00013911986,0.0002523745,0.0010696864,0.002805988,0.8738916,0.11581234],"study_design_scores_gemma":[0.000052162428,0.00007464935,0.019228434,0.00015576313,0.000050468196,0.000092824426,0.00012626433,0.00019054873,0.0009831123,0.00016859367,0.9788529,0.000024327004],"about_ca_topic_score_codex":0.8458661,"about_ca_topic_score_gemma":0.9067248,"teacher_disagreement_score":0.15413392,"about_ca_system_score_codex":0.021162566,"about_ca_system_score_gemma":0.04312182,"threshold_uncertainty_score":0.31008327},"labels":[],"label_agreement":null},{"id":"W4253209358","doi":"10.2165/00128413-200213670-00012","title":"COX-2 inhibitor use increased after formulary listing in Canada","year":2002,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Formulary; Medicine; Listing (finance); Pharmacy; Family medicine; Business","score_opus":0.016917552570486872,"score_gpt":0.22059349375602702,"score_spread":0.20367594118554014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253209358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9752593,0.0017103929,0.00010968417,0.0041041877,0.000100942154,0.000039839815,0.007789623,0.0000515716,0.010834503],"genre_scores_gemma":[0.9884849,0.001255429,0.00013925598,0.0006857071,0.000036028792,0.000009772587,0.0015571112,0.000016368751,0.00781545],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99933344,0.00003682517,0.000043061365,0.000061615305,0.00025704424,0.00026805082],"domain_scores_gemma":[0.99694127,0.00021513258,0.00067269686,0.000045885467,0.0014021277,0.0007229163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021996762,0.00014719844,0.00025414646,0.0010051928,0.001381814,0.0011452079,0.0008328092,0.0006397219,0.007117775],"category_scores_gemma":[0.0026928692,0.00021720513,0.00039436354,0.0030176507,0.00033039265,0.00042284635,0.00037673232,0.0011444461,0.00033753025],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004053029,0.000098139906,0.9719686,0.00006817026,0.000053427655,0.00065177964,0.00055116194,0.00019539222,0.00051563454,0.0002901333,0.006778183,0.018424133],"study_design_scores_gemma":[0.000015488931,0.000031729436,0.9944254,0.000031385538,0.000028830063,0.00015702815,0.0007648475,0.00023277209,0.00016410144,0.000020820087,0.0041185697,0.000009007126],"about_ca_topic_score_codex":0.99056566,"about_ca_topic_score_gemma":0.9936621,"teacher_disagreement_score":0.022873566,"about_ca_system_score_codex":0.022873566,"about_ca_system_score_gemma":0.031031111,"threshold_uncertainty_score":0.16596013},"labels":[],"label_agreement":null},{"id":"W4254352082","doi":"10.2165/00128413-200816570-00002","title":"The 2008 clinical type 2 diabetes guidelines from the Canadian Diabetes Association (CDA) include the new class of DPP-IV* inhibitors.","year":2008,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Type 2 diabetes; Drug class; Diabetes mellitus; Internal medicine; Pharmacology; Endocrinology; Drug","score_opus":0.05587108759421896,"score_gpt":0.3279714595386067,"score_spread":0.27210037194438774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254352082","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008499066,0.2156353,0.010542701,0.25528604,0.073313504,0.001177456,0.027981615,0.0014612863,0.40610307],"genre_scores_gemma":[0.048554953,0.28915554,0.06611491,0.1825794,0.01585307,0.0011948376,0.044251505,0.00060448755,0.3516913],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99783933,0.000187072,0.00018116154,0.00007437394,0.0014810828,0.00023691638],"domain_scores_gemma":[0.9942027,0.00044531404,0.00039765178,0.00011628615,0.0038248638,0.0010132706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021523302,0.0006552094,0.00084332353,0.0012916033,0.0011948883,0.001727762,0.0012861933,0.00209546,0.020274278],"category_scores_gemma":[0.0053128554,0.00025323895,0.0008458574,0.0025946442,0.00054168084,0.0006622681,0.0007759121,0.0056309784,0.009470943],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013158024,0.00007784534,0.0007452378,0.00024436525,0.000013407661,0.000057018195,0.000025904743,0.00003555437,0.00015021433,0.0009091019,0.8903506,0.1072593],"study_design_scores_gemma":[0.00010122681,0.000039912524,0.0038964958,0.00056343165,0.000039043352,0.00024204257,0.000062770494,0.00006542972,0.00016688016,0.00036286478,0.9944423,0.000017620101],"about_ca_topic_score_codex":0.23243055,"about_ca_topic_score_gemma":0.5008526,"teacher_disagreement_score":0.7675694,"about_ca_system_score_codex":0.0036147302,"about_ca_system_score_gemma":0.017223015,"threshold_uncertainty_score":0.46215528},"labels":[],"label_agreement":null},{"id":"W4254520879","doi":"10.2165/00128413-200514750-00059","title":"Abbott Laboratories' lansoprazole [Prevacid] has been approved in Canada","year":2005,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Lansoprazole; Pharmacy; Family medicine; Internal medicine","score_opus":0.26345220313296047,"score_gpt":0.38452366458628245,"score_spread":0.12107146145332198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254520879","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06773016,0.070912674,0.0042661387,0.1598142,0.010506542,0.0009212979,0.015242353,0.003078962,0.66752774],"genre_scores_gemma":[0.35099328,0.02544434,0.0061830003,0.025593318,0.0023541837,0.00021063567,0.011381207,0.00041457784,0.5774254],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983175,0.00023187965,0.00010165385,0.00015499754,0.0008307363,0.00036335902],"domain_scores_gemma":[0.9949485,0.00044177668,0.0003066405,0.000107897664,0.0030713042,0.0011238382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014002636,0.00040097997,0.0007239922,0.0009213221,0.0017264967,0.001679439,0.0009855016,0.0020611363,0.040980037],"category_scores_gemma":[0.0032396135,0.00035768855,0.00062094466,0.0009097332,0.0009498156,0.00037589303,0.0005210899,0.0029090426,0.009608331],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028136612,0.00039131267,0.01160272,0.0006650748,0.00011077731,0.0009932426,0.000105445695,0.00035957908,0.005129551,0.006180564,0.62471604,0.346932],"study_design_scores_gemma":[0.0013869824,0.00081218267,0.03566045,0.00031678844,0.00014411035,0.0010270554,0.00010207256,0.0006619779,0.0030074313,0.00041103596,0.95642275,0.000047110607],"about_ca_topic_score_codex":0.54486287,"about_ca_topic_score_gemma":0.7380167,"teacher_disagreement_score":0.45513713,"about_ca_system_score_codex":0.00834025,"about_ca_system_score_gemma":0.037602767,"threshold_uncertainty_score":0.91563505},"labels":[],"label_agreement":null},{"id":"W4255149466","doi":"10.2165/00128413-200715780-00050","title":"Health Canada advises of health risks with EMPowerplus","year":2007,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Global Public Health Policies and Epidemiology","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacy; Environmental health; Family medicine","score_opus":0.04979907539551033,"score_gpt":0.35108238039091794,"score_spread":0.3012833049954076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255149466","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003950835,0.0018903571,0.0016506569,0.51463515,0.008031601,0.00038157523,0.004431719,0.0012270027,0.46380115],"genre_scores_gemma":[0.038750067,0.002814894,0.005204397,0.1999173,0.003704296,0.000169327,0.002010452,0.00043916624,0.7469901],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946062,0.00081531826,0.00021648807,0.00022108405,0.0029419626,0.0011989679],"domain_scores_gemma":[0.9605062,0.0102718705,0.0008003881,0.00073733623,0.013998571,0.013685663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0052549466,0.0005480828,0.00053737574,0.0026012324,0.0046259314,0.00378357,0.0016461681,0.0067510367,0.12803169],"category_scores_gemma":[0.026416468,0.0005604666,0.0008439944,0.0017940617,0.0013500603,0.001318101,0.0018219538,0.006230048,0.0113243675],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017247226,0.00004601665,0.0014473542,0.000019580906,0.0000059593854,0.00007299625,0.00005657295,0.00006751185,0.00004696396,0.0017309631,0.97537744,0.021111388],"study_design_scores_gemma":[0.00004372343,0.0000217001,0.0025977762,0.000055911918,0.000017344393,0.000066715744,0.0002366892,0.0003032829,0.00016462477,0.0011471686,0.99532926,0.000015867912],"about_ca_topic_score_codex":0.8026877,"about_ca_topic_score_gemma":0.92507094,"teacher_disagreement_score":0.1973123,"about_ca_system_score_codex":0.0148734,"about_ca_system_score_gemma":0.12204456,"threshold_uncertainty_score":0.42830867},"labels":[],"label_agreement":null},{"id":"W4255248028","doi":"10.2165/00128413-200515060-00058","title":"Cetuximab [Erbitux; Bristol-Myers Squibb, ImClone Systems] injection has been approved by Health Canada's Biologics and Genetic Therapeutics Directorate","year":2005,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Bristol-Myers; Cetuximab; Family medicine; Pharmacy; Pharmacology; Internal medicine; Cancer","score_opus":0.2486589550439336,"score_gpt":0.37565794022969595,"score_spread":0.12699898518576236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255248028","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09386753,0.011991928,0.009027215,0.021686375,0.0033263213,0.0016407802,0.02088336,0.002856357,0.8347202],"genre_scores_gemma":[0.18576182,0.0031950718,0.0053325132,0.0022464963,0.00039087818,0.00014806296,0.008085967,0.00024078849,0.7945984],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99949265,0.000073943505,0.000019709123,0.000045081342,0.00027396713,0.00009472702],"domain_scores_gemma":[0.9990885,0.00009484027,0.00007150506,0.000056611894,0.00045410896,0.00023448492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092928135,0.000320196,0.00043286374,0.0005003433,0.00069595635,0.0011182113,0.00052401965,0.000668551,0.0776055],"category_scores_gemma":[0.0015614303,0.00024229658,0.0002645063,0.00038650588,0.00042641815,0.00031564207,0.00030457525,0.00095317746,0.014012314],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039913934,0.0007148228,0.0059715174,0.00029312205,0.00009454915,0.00032897654,0.000104337654,0.0006372215,0.016396577,0.009068693,0.52715904,0.4352398],"study_design_scores_gemma":[0.0012004268,0.0010110632,0.03043952,0.00014879016,0.0001208801,0.0005793873,0.000046149387,0.0020441604,0.018591745,0.00047973657,0.94531083,0.00002717058],"about_ca_topic_score_codex":0.07138503,"about_ca_topic_score_gemma":0.18588345,"teacher_disagreement_score":0.928615,"about_ca_system_score_codex":0.002996794,"about_ca_system_score_gemma":0.008723989,"threshold_uncertainty_score":0.25961626},"labels":[],"label_agreement":null},{"id":"W4255619675","doi":"10.2165/00128413-200112960-00010","title":"Antipsychotic polypharmacy in schizophrenia in Canada","year":2001,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Polypharmacy; Medicine; Antipsychotic; Schizophrenia (object-oriented programming); Psychiatry; Pharmacy; Pharmacology; Family medicine","score_opus":0.02528746022205306,"score_gpt":0.30873497216507567,"score_spread":0.2834475119430226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255619675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9527765,0.009339172,0.00017258506,0.016055608,0.00028875863,0.000100543344,0.0073825372,0.00003848019,0.013845994],"genre_scores_gemma":[0.9857738,0.0054548546,0.00027930902,0.001537255,0.000087599794,0.000023800456,0.0012557392,0.000017386368,0.005570267],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991304,0.00007950976,0.00007693338,0.00005457329,0.00033302561,0.00032557055],"domain_scores_gemma":[0.99606234,0.00020116825,0.0006460028,0.000028903363,0.0014184513,0.0016431907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041418284,0.00018462834,0.0004394119,0.0016372786,0.0024551256,0.001312312,0.0008586993,0.0007652978,0.0047464743],"category_scores_gemma":[0.0026989523,0.00033569033,0.00050914293,0.0042456333,0.00049599836,0.00041878328,0.0006983262,0.0011136024,0.00024922256],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000689772,0.00026429296,0.9267282,0.00029804002,0.0001485425,0.00090446474,0.0010957381,0.0006369114,0.0004974779,0.0013702665,0.017870244,0.04949618],"study_design_scores_gemma":[0.00011012964,0.00007699624,0.99011594,0.00011700621,0.00006530188,0.00034848615,0.0014285657,0.0007848391,0.00009334298,0.00011598909,0.0067163245,0.000027129327],"about_ca_topic_score_codex":0.99706084,"about_ca_topic_score_gemma":0.99854004,"teacher_disagreement_score":0.048232954,"about_ca_system_score_codex":0.048232954,"about_ca_system_score_gemma":0.09468495,"threshold_uncertainty_score":0.3499562},"labels":[],"label_agreement":null},{"id":"W4255733503","doi":"10.2165/00128413-200414370-00056","title":"Health Canada has approved a new two-dose regimen of Meningococcal group C conjugate vaccine [NeisVac-C; Shire Biologics]","year":2004,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Bacterial Infections and Vaccines","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Regimen; Shire; Pharmacy; Meningococcal vaccine; Pharmacology; Family medicine; Internal medicine; Virology; Immunology; Immunization","score_opus":0.024698739203132227,"score_gpt":0.26563162755062075,"score_spread":0.24093288834748852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255733503","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.37164244,0.048520602,0.019664165,0.08710017,0.019686868,0.008178282,0.018637031,0.0043952386,0.42217523],"genre_scores_gemma":[0.55227625,0.021924501,0.025425049,0.039271437,0.002370046,0.00097244506,0.014240918,0.00026086258,0.3432585],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993736,0.00008020669,0.000017653114,0.00004516578,0.0003500556,0.00013333335],"domain_scores_gemma":[0.9985715,0.00013238259,0.000086915876,0.000050241495,0.00052851986,0.0006304379],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008581186,0.00041876535,0.00057989295,0.0005258592,0.00094167923,0.0006476664,0.0014408407,0.0020114004,0.01303863],"category_scores_gemma":[0.00084503,0.00025658973,0.00045241223,0.00036152525,0.0005499872,0.00020439053,0.00024064699,0.0021477798,0.002155696],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005795042,0.004930918,0.012187557,0.0004965877,0.00019367413,0.0008351508,0.00013141154,0.0015328493,0.04817911,0.0031744298,0.35988218,0.56266105],"study_design_scores_gemma":[0.0035432738,0.0064294175,0.035958007,0.00012307987,0.00013180786,0.00091201183,0.000087190165,0.0013278069,0.010793295,0.0002235449,0.9404214,0.0000490974],"about_ca_topic_score_codex":0.2840389,"about_ca_topic_score_gemma":0.6161859,"teacher_disagreement_score":0.7159611,"about_ca_system_score_codex":0.0047382014,"about_ca_system_score_gemma":0.01586913,"threshold_uncertainty_score":0.56477123},"labels":[],"label_agreement":null},{"id":"W4256035456","doi":"10.2165/00128413-200715930-00041","title":"New Avastin safety info issued in Canada","year":2007,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacy; Traditional medicine; Family medicine; Optometry; Ophthalmology","score_opus":0.014390874321892982,"score_gpt":0.30848279498024395,"score_spread":0.294091920658351,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4256035456","genre_codex":"other","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014343864,0.014337941,0.0017708878,0.09018544,0.020355472,0.00061116694,0.043001186,0.002211116,0.813183],"genre_scores_gemma":[0.018798681,0.004011157,0.00066904014,0.008913349,0.0014795389,0.00003627405,0.0068786936,0.00017199553,0.95904124],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985428,0.000042167474,0.000039935854,0.000049318714,0.0011249091,0.00020104263],"domain_scores_gemma":[0.994429,0.000408928,0.00022746816,0.000098747325,0.0036991374,0.0011367379],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009318619,0.000456498,0.0006124419,0.0020268895,0.0025764916,0.0042006318,0.00079338084,0.0030929307,0.095555015],"category_scores_gemma":[0.003541746,0.0004966981,0.00055551913,0.0015937178,0.0006098377,0.0005524879,0.00052177976,0.0029201824,0.017574767],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008782913,0.000038735863,0.0012377268,0.00006583985,0.0000072300068,0.00014381156,0.000025636364,0.00009543104,0.00034020693,0.000805761,0.97298145,0.024170306],"study_design_scores_gemma":[0.000038541864,0.000041064828,0.007952723,0.000064865555,0.000014927431,0.000078693745,0.000050473616,0.00023172164,0.00045403696,0.0002269898,0.9908303,0.00001565138],"about_ca_topic_score_codex":0.8057409,"about_ca_topic_score_gemma":0.9205989,"teacher_disagreement_score":0.1942591,"about_ca_system_score_codex":0.016224708,"about_ca_system_score_gemma":0.051823787,"threshold_uncertainty_score":0.39080626},"labels":[],"label_agreement":null},{"id":"W4256130786","doi":"10.2165/00128413-200112980-00008","title":"Emergency oral contraception cost saving in Canada","year":2001,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Reproductive Health and Contraception","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Emergency contraception; Pharmacy; Oral contraception; Medical emergency; Family medicine; Family planning; Population; Environmental health; Research methodology","score_opus":0.035237739672485925,"score_gpt":0.3261805814117229,"score_spread":0.29094284173923696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4256130786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6586185,0.031328402,0.0004029881,0.11739091,0.001596607,0.00034040574,0.042849723,0.00024120754,0.14723125],"genre_scores_gemma":[0.91774553,0.017364278,0.00078658276,0.008322121,0.00033351593,0.00006739529,0.00475778,0.00008639749,0.050536484],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99812573,0.00012129018,0.0000894789,0.00008412293,0.00076957484,0.0008097503],"domain_scores_gemma":[0.9952297,0.00032642434,0.00035969127,0.000049121714,0.0022430206,0.0017919762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056938856,0.00033447432,0.0005514648,0.0022847503,0.0026584247,0.002640526,0.0013668147,0.0013392849,0.014955948],"category_scores_gemma":[0.004907855,0.00045746416,0.0009285986,0.0052667824,0.0006375494,0.0005247429,0.00076524087,0.0016290932,0.00040308078],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022581648,0.0005428433,0.3530426,0.0014310672,0.0005824914,0.0027287195,0.00095335674,0.009157092,0.00059351086,0.022474688,0.3711464,0.23508902],"study_design_scores_gemma":[0.000751177,0.00024731012,0.8449502,0.00084028003,0.00054246734,0.0010967291,0.0029298,0.006769574,0.0004934241,0.0015082585,0.13974103,0.000129653],"about_ca_topic_score_codex":0.9975904,"about_ca_topic_score_gemma":0.9988432,"teacher_disagreement_score":0.113308735,"about_ca_system_score_codex":0.113308735,"about_ca_system_score_gemma":0.1945984,"threshold_uncertainty_score":0.82211626},"labels":[],"label_agreement":null},{"id":"W4256723626","doi":"10.2165/00128413-200716000-00066","title":"Dronabinol/cannabidiol [Sativex; Bayer, GW Pharmaceuticals] has been approved by Health Canada for adults with moderate to severe cancer pain","year":2007,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Dronabinol; Cannabidiol; Pharmacy; Cancer; Traditional medicine; Family medicine; Cannabis; Psychiatry; Internal medicine; Cannabinoid","score_opus":0.030749402716131444,"score_gpt":0.34557481624392733,"score_spread":0.31482541352779586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4256723626","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6300026,0.057012413,0.0033701928,0.013038565,0.002064585,0.0020538557,0.0081964135,0.0023008639,0.28196052],"genre_scores_gemma":[0.88330054,0.014644371,0.004807237,0.004028729,0.00030292894,0.0001822928,0.004476421,0.00009921614,0.0881582],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997781,0.000033775967,0.00001668965,0.000027805594,0.000089050656,0.000054616066],"domain_scores_gemma":[0.99961436,0.00005393152,0.000074982825,0.000027260408,0.00009717093,0.0001323357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003252516,0.00030723884,0.00062135694,0.0004901556,0.0009357272,0.0004225439,0.0006703128,0.0010067957,0.024299882],"category_scores_gemma":[0.00065197964,0.00019088178,0.00039450132,0.00040256084,0.000502022,0.0003213152,0.00036914137,0.0013804539,0.003558973],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014058844,0.0029326796,0.008637522,0.0023130104,0.0003051274,0.0021933126,0.00023063307,0.00029371478,0.15215826,0.0030987458,0.06559033,0.7481879],"study_design_scores_gemma":[0.018710107,0.022445282,0.15731044,0.00078144606,0.00083996175,0.0125079965,0.0005642971,0.0026852733,0.12818679,0.0013464064,0.6543967,0.0002251726],"about_ca_topic_score_codex":0.02289265,"about_ca_topic_score_gemma":0.08555372,"teacher_disagreement_score":0.97710735,"about_ca_system_score_codex":0.00090783293,"about_ca_system_score_gemma":0.002417626,"threshold_uncertainty_score":0.08129126},"labels":[],"label_agreement":null}]}